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Chapter 1  
Introduction 
Summary 
The focus of this thesis is the pylorus, an anatomical sphincter that controls the passage of food 
from the stomach to the duodenum. Malformation or malfunction of this sphincter results in two 
significant pathologies: idiopathic hypertrophic pyloric stenosis (IHPS) occurs when the pylorus 
is obstructed or tonically closed, while duodenogastric reflux (DGR) is a consequence of failure 
to properly close the pyloric sphincter. Neither the developmental history of the pylorus nor the 
molecular pathoetiologies that underlie these severe pathologies are clearly understood; the work 
described here was undertaken further explore both of these aspects. In this first chapter, I will 
summarize what is known about the anatomy of the pyloric region, its embryonic development 
and the genetic network involved in its maturation. Additionally, I will describe the major 
pyloric pathologies in terms of their presentation, epidemiology, diagnosis and treatment. Since 
at least in the case of IHPS, a strong genetic component has been clearly demonstrated, I will 
also review some of the genetic associations that have been implicated in that condition. This 
will set the stage for the presentation of my experimental work in Chapters 2 and 3. In Chapter 4, 
I will consider the implications of the data that I have gathered in the context of pyloric 
development and disease, and suggest future studies that could impact the diagnosis and 
treatment of IHPS and DGR and shed additional light on the factors involved in pyloric 
ontogeny.   
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1.1 Major divisions of the gastrointestinal tract  
The gastrointestinal tract of the mouse and human are structurally very similar [1].  Food enters 
through an oral cavity and is propelled down the short, straight esophagus by the action of 
swallowing (Figure 1.1A). A gastroesophageal sphincter controls the entry of food into the 
stomach, where it is partially digested by the actions of gastric acid and proteases. The pyloric 
sphincter, which is positioned between the stomach and small intestine, regulates progression of 
the partially digested food, known as chyme, into the small intestine, where further digestion and 
absorption take place. Several specialized anatomical terms are used to describe specific areas of 
the stomach and intestine and are important in the context of this thesis. In the mouse, the most 
anterior portion of the stomach, called the forestomach, is histologically an extension of the 
esophagus; it is covered by squamous, non-keratinized epithelium an epithelium able to 
withstand the coarse diet of the mouse, which may contain hair and dirt. Humans lack this 
specialized forestomach region. The glandular stomach (also called “body”, “corpus” or 
“fundus”) is the most anterior region in the human, but located in the central area of the stomach 
in the mouse. In the chick, another model in which pyloric development has been well-studied, 
this glandular region is called the proventriculus. In all species, the glandular stomach is the site 
of secretion of acid as well as digestive enzymes like pepsin. 
 
The posterior stomach, referred to in humans and mice as the antrum (or pyloric stomach), is an 
important site of mucus production (Figure 1.1B); this heavy mucus layer protects the pylorus 
and nearby duodenum from the acid produced by the corpus. In the chick, this region is called  
the gizzard. It is highly muscular and may contain stones and grit; its function is to grind the 
food, serving part of the function of the teeth, which are lacking in the chicken. The muscular 
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Figure1.1 The normal mouse gastrointestinal system 
(A) Food travels from the oral cavity, through the esophagus, and undergoes mechanical 
disruption and acid breakdown in the stomach. Then it is further digested and absorbed while 
traveling through the three regions of the small intestine: the duodenum, jejunum, and ileum. 
Finally, the food is dehydrated in the colon, where colonic bacteria break down important 
nutrients and prepare stool for excretion. (B) An inset of the stomach and proximal duodenum 
(red box, A). The stomach is divided into three portions, the anterior forestomach, the corpus or 
fundus, and the distal antrum. The antrum is connected to the proximal duodenum via the 
pylorus. 
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pyloric sphincter controls gastric emptying to the small intestine. Posterior to the pylorus, the 
small intestine is divided into distinct regions from anterior to posterior: these are termed the 
duodenum, jejunum, and ileum.  
 
The focus of this thesis is the pylorus. Functionally, the pylorus not only regulates food passage 
between the antrum and duodenum by allowing the regular emptying of the stomach, but 
additionally, since it is tonically constricted except when signaled to open, it serves to prevent 
the backflow of duodenal contents into the stomach [2]. The pylorus is a true, or anatomic, 
sphincter; that is, it is associated with a muscular thickening that can adjust the lumenal diameter 
using muscular tone. This is in contrast to the so-called “physiological” sphincter that defines the 
transition from the esophagus to stomach, which controls flux using a pressure gradient 
generated by the diaphragm. At the pyloric sphincter, constriction is regulated by a complex and 
coordinated series of inputs from the nervous system, hormonal signaling, interstitial cells of 
Cajal (pacemaker cells) and intrinsic muscular tone. Abnormalities in the sphincter or in any of 
these inputs could potentially result in pyloric dysfunction. 
 
Two clinically significant diseases of pyloric function have been described: infantile 
hypertrophic pyloric stenosis (IHPS) and duodenogastric reflux (DGR). The first is thought to 
arise from tonic closure of the pylorus, preventing the passage of food to the duodenum, while 
the latter is a consequence of inability to maintain pyloric closure, thus allowing backward 
movement of duodenal contents and bile into the stomach. While most individuals probably 
suffer periodically from DGR, congenital DGR is a rare condition, for which there is no known 
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molecular underpinning [3, 4]. In contrast, IHPS is one of the most common birth anomalies and 
its genetic basis is just beginning to emerge [5-8].  
 
1.2 Pyloric morphology 
Like the rest of the GI tract, the pylorus is composed of cells from all three germ layers. The 
epithelium is derived from endoderm, while the underlying lamina propria and muscular 
components are mesenchymal. Neuronal cells of ectodermal origin innervate the pylorus and 
control its function. In the avian model, the epithelium in the region of the pylorus is distinct 
from that of the nearby gizzard and duodenum [5]. Gizzard epithelial cells have a keratin layer 
and long cilia, likely to resist the abrasive grinding critical in the normal function of the avian 
gizzard. In contrast, the avian pyloric epithelium lacks the keratin layer and has short, bulbous 
cilia, while the duodenal epithelium lacks cilia entirely. Interestingly, the adult mammalian 
pylorus lacks a unique pyloric epithelium. Rather, the pylorus is the site of an abrupt junction 
between antral and duodenal epithelial cell types [6]. As measured by intestinal markers such as 
Cdx2 and villin, this epithelial boundary is one cell thick: at the pylorus, a cell expressing 
multiple intestinal markers lies immediately adjacent to cells expressing stomach markers [6]. 
This distinct boundary evolves from an earlier, more graded expression pattern in which cells 
expressing gastric markers (SOX2) overlap for a short distance at the pylorus with cells that 
express intestinal markers (e.g., Cdx2) [7]. The conversion of this graded border to the sharp 
boundary of epithelial cell types characteristic of the adult occurs at E16.5 in the mouse [6].   
 
The pyloric mesenchyme is composed of several concentric layers. The lamina propria is the 
layer closest to the epithelium; it contains blood vessels, immune cells, lymphatics, fibroblasts 
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and myofibroblasts. A thin muscularis mucosa underlies the epithelium and lamina propria. The 
submucosal layer is not well developed at the pylorus; rather it is dominated by the muscularis 
externa, consisting of an inner circular muscle (ICM) and an outer longitudinal muscle (OLM). 
The myenteric plexuses of the enteric nervous system lie in between the ICM and OLM (Figure 
1.2).  
 
The inner circular muscle of the GI tract forms a circumferential sheath around the tubular gut, 
with the fibers of the muscle oriented perpendicularly from the anterior-posterior (A-P) axis. The 
ICM forms at approximately embryonic day (E) 11, as judged by increasing expression of the 
muscular protein alpha smooth muscle actin [8]. The OLM arises 24 to 48 hours later, with fibers 
oriented down the length of the gut tube. The thickness of these muscular layers is variable 
throughout the length of the GI tract. The gastric ICM is relatively thick and arranged into 
fascicular bundles. It thickens considerably at the pylorus with the fascicles oriented obliquely 
relative to those of the stomach. The ICM thins considerably on the duodenal side of the pylorus 
and changes relatively little throughout the rest of the small intestine. The OLM undergoes 
similar morphological changes but with a vastly decreased thickness relative to the ICM.  
 
A complex network of innervations control the contraction or relaxation of the pyloric sphincter 
through excitatory and inhibitory signals, respectively [9, 10]. The extrinsic innervations at the 
pylorus include both sympathetic and parasympathetic neurons from the peripheral nervous 
system. Sympathetic stimulation at the pylorus is primarily excitatory, while parasympathetic 
innervations can have either an excitatory effect through cholinergic signaling or an inhibitory 
effect through vasoactive intestinal peptide (VIP) and nitric oxide (NO) signaling. The majority 
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Figure 1.2 Schematic of the embryonic pylorus  
A schematic of the E16.5 embryonic pylorus illustrates its component layers. The epithelium 
transitions from the glandular epithelium of the antrum (left) to the villus epithelium of the 
duodenum (right). The region known as the mucosa includes epithelium, lamina propria and 
underlying thin muscularis mucosa (red dotted line). Below the mucosa lies the submucosa, 
filled with connective tissue (blue dotted line) and the two layers of the muscularis externa, the 
ICM and OLM. Between these muscular layers are the neurons of Auerbach’s myenteric plexus. 
Squamous serosal (mesothelial) cells cover the surface of the stomach, pylorus and intestine. 
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of the fibers at the pylorus appear to be fibers of the vagus nerve carrying afferent sensory 
signals [13]. These fibers relay signals to the CNS from the muscle stretch receptors. 
Interestingly, studies show that the net extrinsic innervation at the pylorus is inhibitory, with 
denervation of the pylorus resulting in decreased flux of solid food content [2]. In addition, the 
myenteric plexus within the muscularis externa provides the intrinsic innervation to the pylorus 
[11]. The ganglia of the myenteric plexus are large and embedded between the two layers of the 
muscularis mucosa. They provide either excitatory signals through enkephalins and substance P 
or inhibitory signals through VIP and NO [9]. Interstitial cells of Cajal serve as the pacemaker 
cells which lead to the basal contractile rhythm of the GI tract. At the pylorus, these cells appear 
to form gap junctions with each other and with smooth muscle rather than with nervous 
extensions [10], suggesting an important role for cell-cell contacts in maintaining pyloric 
constriction.  
 
1.3 Pyloric Pathologies 
Having summarized normal pyloric physiology, I will describe the two primary pathologies of 
the pylorus: duodenogastric reflux and infantile hypertrophic pyloric stenosis.  These pathologies 
have been well described functionally in both the clinic and in animal models, with surgical 
interventions for IHPS being described as early as the turn of the 20th century [12]. However, 
there is still a significant amount of ongoing investigation into the pathogenesis of both diseases. 
New molecular markers and genetic assays are providing insights into the varied etiologies by 
which DGR and IHPS arise [13]. Here I will describe the clinical presentation of both illnesses 
and then describe the current understanding of these etiologies.  
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1.3.1 Duodenogastric Reflux 
Duodenogastric reflux results from a defect in pyloric closure and is therefore the phenotypic or 
functional opposite of IHPS.  Mild duodenal reflux into the stomach likely occurs in nearly 
everyone at some time and is normally asymptomatic. Pathologic DGR occurs when this reflux 
is excessive or occurs extensively over a period of time [3]. There are a number of overlapping 
definitions of the nature of the reflux, including reflux of duodenal contents into either the 
stomach or duodenum, and reflux of biliary contents anywhere along the biliary tree. Here, I will 
focus on describing the clinical presentation DGR, where duodenal contents reflux into the 
stomach, causing inflammatory changes in the gastric mucosa, called bile reflux gastritis (BRG). 
I will then explore the pathogenesis of this disease in an animal model. 
 
Clinical presentation of DGR 
Early studies of DGR primarily identified this pathology as resulting from a number of surgical 
interventions, including gastric surgery, pyloroplasty, and cholecystectomy [4, 14]. The 
condition was often defined by clinical presentation, with bilious vomit being the first clue that a 
chronic reflux problem was occurring. Analysis of the gastric contents in fasting patients 
frequently demonstrated bile acid and the gastric mucosa was likely to show several prototypical 
changes: foveolar hyperplasia, vascular congestion, edema, smooth muscle infiltration, and a 
lack of inflammatory cells. This presentation is distinct from the chronic gastritis found in 
patients colonized with Helicobacter pylori infection. In fact, several studies have demonstrated 
that bile reflux actually decreases the prevelance of H. pylori and partially resolves the chronic 
inflammatory response [15-18]. Subsequent studies in normal patient populations showed that 
there exists a significant population of patients that present with primary BRG (BRG without 
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prior midgut surgery) [19, 20]. These patients present with similar symptoms as the post-
operative patients, including nausea, vomiting, and epigastric pain. Pediatric patients differ from 
their adult cohort only in that there is a significant negative correlation between vascular 
congestion and DGR in children, in direct contrast to the earlier findings. These studies leave 
several unanswered questions regarding the presentation and progression of this disease. In 
addition, there is no clear correlation between the degree of DRG and the nature of the 
histological changes in the stomach [15, 21]. 
 
Pathogenesis of DGR   
The causes underlying the development of primary DGR are currently unclear and the existing 
studies are fairly limited. The only mouse model is the W/Wv mouse, which exhibits loss of c-kit 
and therefore loss of the interstitial cells of Cajal, the pacemaker cells of the gut [22]. Extensive 
bile acid staining of the gastric mucosa in these mice, when studied post-mortem, was taken as 
diagnostic of DGR. An orthologous rat model, the Ws/Ws rat, shows similar reflux symptoms, 
with increased concentrations of bile acid in the stomach [23]. While the specific mechanism by 
which increased bile acid causes metaplastic gastritis is still unclear, several studies have shown 
correlative links between the two pathologies [3, 17, 21]. Increased bile acid reflux is associated 
with marked intestinal metaplasia in the stomach. Specifically, the formation of absorptive, 
goblet, or Paneth cells within the gastric mucosa. This is generally believed to be the first step in 
the progression toward gastric cancer and greatly increases the likelihood of developing gastric 
cancer [15, 17]. 
 
1.3.2 Infantile Hypertrophic Pyloric Stenosis 
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IHPS is a developmental disorder of the pylorus. Several excellent reviews on IHPS have 
recently been published [24]; the most salient aspects from those reviews are highlighted here. 
IHPS is relatively common, reported to occur in 1.5 to 3 in every 1000 live births, with slight 
variations depending on social and ethnic demographics [9, 24-26]. Interestingly, IHPS is much 
more common in males, with a male:female ratio of 4-5:1, though the reason for this is unclear. 
Clinical symptoms of IHPS typically arise 3-5 weeks after birth, with rare cases arising as soon 
as the first few weeks of life. Infants typically present with spitting, which can progress to 
projectile vomiting following feedings, sometimes so forceful that vomitus is ejected from the 
nose as well. It may contain brownish, “coffee ground” material, likely the dried remnants of GI 
bleeding. The infant may also present with wasting and dehydration, but this is dependent on the 
severity and duration of the symptoms. The tonically closed pylorus can be palpated; a pyloric 
mass or “olive,” is present upon physical examination in 70-90% of affected infants [27]. 
Diagnosis is confirmed by abdominal ultrasound, in which the pylorus appears as a bright donut. 
IHPS can be successfully treated surgically. A procedure called a pyloromyotomy is done to 
relieve the tension on the pylorus (Figure 1.3; [28]). Specifically, a longitudinal incision is made 
along the greater curvature of the hypertrophic pylorus, with subsequent blunt dissection to the 
level of the submucosa. Complete healing takes place within approximately a month and this 
seems to restore proper function to the pylorus. Complications from this procedure are rare but 
can include duodenal perforation, infection, gastroesophageal reflux, and vomiting [29, 30]. 
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Figure 1.3 Laparoscopic pyloromyotomy 
Images taken from a laparoscopic pyloromyotomy demonstrate the longitudinal incision made 
along the hypertrophied pyloric musculature with the retractable pyloromyotomy blade (white 
arrows). Then the pyloric spreader is used to complete the surgery. The lower right image shows 
the completed procedure and extent of the incision (white string = 2 cm). (Image reprinted from 
St. Peter et al. 2006 with permission from Wolters Kluwer Health). 
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Much is known about the epidemiology and presentation of IHPS and, properly surgically 
treated, it seldom results in fatality. However, significant morbidity is associated with this 
condition, justifying a continued search for its cause. Muscular, nervous, hormonal and epithelial 
pathologies have all been postulated in IHPS, but the various studies have found disparate and 
conflicting evidence, possibly suggesting that several unique subtypes of IHPS exist. 
 
Muscular pathology 
Obvious attention has been paid to possible abnormalities in the muscles that form the pyloric 
sphincter.   In some cases of IHPS, swollen smooth muscle cells with dilated rough endoplasmic 
reticulum, excess glycogen, and abnormal, enlarged mitochondria have been documented [32, 
33], suggesting that pyloric obstruction could result from cellular hypertrophy. However, a 
subsequent study found roughly normal smooth muscle cells, with only an increase in rough 
endoplasmic reticulum at the pylorus [31]. This latter study also reports that the smooth muscle 
cells in IHPS are more commonly in a proliferative state than those in the normal pylorus, 
implicating hyperplasia instead of hypertrophy as a mechanism behind pyloric stenosis. In 
support of these findings, another study found that IHPS cells express increased amounts of the 
protein desmin, a protein that is highly expressed during myogenesis [32]; the authors speculated 
that the increased desmin expression might be a sign of a poorly differentiated (fetal-like) 
muscle. This study was contradicted a few years later, by a group that showed that the muscular 
proteins desmin and alpha-smooth muscle actin were expressed at similar levels in control and 
IHPS patients. Rather, the cytoskeletal proteins talin and dystrophin were absent in IHPS [33]. 
Reduced levels of these proteins could lead to impaired cell-matrix and membrane-cytoskeletal 
interactions, respectively, resulting in loss of pyloric myogenic structural integrity and tone. In 
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support of altered interactions between muscle cells and the extracellular matrix, a more recent 
study demonstrated severely reduced sarcoglycan expression [34]. Sarcoglycan is an important 
component of the dystrophin/glycoprotein complex that acts to link the muscle cell to the 
extracellular matrix. Taken together, these data make clear that there is no current consensus on a 
single mechanism by which alterations in the muscular tissue lead to IHPS, and it is possible that 
several myogenically-based etiologies could give rise to this condition.  
 
Neuronal pathology 
Like the abnormalities seen in the smooth muscle cells, many studies of neuronal abnormalities 
in IHPS have focused on the histopathologic findings. Changes in the shape, number, and size of 
the ganglion cells of the myenteric plexus have been documented in IHPS patients by some 
authors [35-38], while normal ganglion number and morphology were seen by others [39-41]. 
Changes in nerve cell bodies and axons have also been seen [39, 42].  Finally, alterations have 
been observed in the contacts between nerve and muscle within the pylorus. Reduced numbers of 
neuromuscular contacts were observed in one study [40] and another reported reduced 
expression of the adhesion molecule NCAM within the pyloric muscle itself, but not in the 
myenteric plexus . Thus, it is possible that alterations in the innervation proper or in the synapses 
between nerve and muscle contribute to IHPS. 
 
As mentioned earlier, several different types of neurotransmitters are involved in pyloric 
signaling, and several of these have been implicated in the pathogenesis of IHPS. One study 
shows that acetylcholinesterase expression decreases in the muscular layers in IHPS tissue 
relative to controls [43]. This increases cholinergic activity at the pylorus and, consequently, 
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pyloric excitation. Other studies have shown a marked decrease in adrenergic staining IHPS 
patient tissue, suggesting that the relative expression of these transmitters could be significant in 
determining the course of this disease. Additionally, decreases in both the excitatory 
neurotransmitters enkaphalin and substance P as well as the inhibitory neuropeptides vasoactive 
intestinal polypeptide and neuropeptide Y have been observed [44, 45].  Panteli speculates that 
the loss of inhibitory neurotransmitters could underlie the inability of the pyloric muscle to relax, 
and the resulting hyper-activated pyloric tissue could consume excitatory neuropeptides [9].  
 
Perhaps the most compelling case for a causative role of a neurotransmitter-like molecule in 
IHPS is that of nitric oxide (NO), an important cell signaling molecule that can also regulate 
muscular tone. NO is generated from L-arginine by neural nitric oxide synthase (nNOS); it is 
believed to act as an inhibitory factor that can stimulate smooth muscle relaxation [46, 47].  A 
number of authors have documented sustained and marked decrease in nNOS in IHPS pyloric 
tissue [22, 48]. One study that followed patients post surgically for the treatment of IHPS found 
that systemic nitrite levels were significantly decreased in IHPS patients before pyloromyotomy, 
but normal afterwards, suggesting that the surgical treatment not only relieves symptomatic 
pyloric pressure but alters signaling modalities at the pylorus [48]. Interestingly, a mouse model 
of nNOS deficiency has been described; these mice exhibit pyloric hypertrophy [22]. The same 
phenotype was seen after administration of a NOS inhibitor to pregnant rats, suggesting that loss 
of NO alone may be enough to cause IHPS  [49]. Together, these data indicate that NO signaling 
is critical in pyloric relaxation and its absence may induce pyloric hypertrophy. 
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Another possible etiology for IHPS is loss or malfunction of the interstitial cells of Cajal (ICC). 
These cells function as electrical pacemakers, networking with neuronal and muscle cells to 
control coordinated peristaltic contractions along the gut tube. Both electron microcopy and 
immunostaining for the ICC marker, c-kit, indicate that the ICC network is disturbed or reduced 
in IHPS [42, 50, 51]. Interestingly, ICC might be required for both nitrergic and choninergic 
responses, since both responses were reduced in c-kit mutant W/Wv mice that lack ICC [52].  
Thus, NO signaling might require ICC and given that NO donors seem to improve ICC survival 
[53], this dependent relationship may be critical to the pathoetiology of IHPS. However, as is the 
pattern with studies on IHPS etiology, a more recent study partially contradicts these findings, 
finding no evidence that ICC are involved in nitrergic inhibition [22]. In that study, pyloric 
sphincter function was measured manometrically and a zone of high pressure was detected at the 
sphincter that was reduced in W/Wv mice but normal in iNOS null mice. In the latter animals, the 
loss of NO resulted in lack of inhibition by vagal stimulation; indeed, a paradoxical excitation 
was detected, which could explain the delayed gastric emptying and beazors seen in this model. 
In contrast, W/Wv mice showed normal nitrergic inhibition in this study and exhibited bile in the 
stomach, characteristic of duodenogastric reflux.   
 
Hormonal alterations 
Though studies in the 1970’s suggested that administration of gastrin to dogs could produce a 
condition like pyloric stenosis [54], a connection between gastrin and IHPS has not been 
reproducibly demonstrated in humans. Other hormones that could influence the function of the 
pyloric muscle include somatostatin, secretin, cholecystokinin, prostaglandins and vasoactive 
intestinal peptide (VIP). All of these have been investigated in various studies. Though two case 
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reports suggest that treatment with prostaglandins can induce pyloric stenosis [55, 56], this has 
not been systematically investigated and the existing evidence for a causal link between any of 
the other hormones and IHPS is not compelling (reviewed in Panteli). 
 
Mucosal etiology 
With much attention paid to other possible etiologies, discussed above, few studies have 
carefully examined the mucosal aspect in cases of IHPS. One extensive study looked at 102 
cases of IHPS and found a consistent thickening of the mucosa, with a mean mucosal thickness 
measured on sonographs of 4.1 ± 0.9 mm in IHPS patients as compared to 2.3 ± 0.5 mm in 51 
controls [57]. Biopsy of one patient showed an abnormally folded epithelium with edematous 
submucosa and inflammation. This histological picture was similar to that shown after 
prostaglandin-induced stenosis, described above [56], a finding that is interesting in light of the 
fact that increased prostaglandin levels have been detected in IHPS [58].  
 
Pathoetiology of IHPS: in search of the cause 
Taken together, all of these data make clear that there is no current consensus on a single 
mechanism by which IHPS arises, and it is possible that several etiologies could give rise to this 
condition. It is also important to keep in mind that most of these studies examine the disease 
endpoint in patients, well after the inciting factor has acted. Because it is very difficult, if not 
impossible, to deduce cause from effect in this manner, there is a great need to generate animal 
models in which IHPS can be reproducibly generated and studied.  
 
1.4 Genetics of IHPS 
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The epidemiology of IHPS makes it likely that this condition arises from genetic susceptibility, 
exacerbated by some environmental/physiological stimulus (e.g., hormonal changes that 
accompany birth, feeding, increased gastric acidity, etc.). Family studies have revealed a strong 
genetic component, with a 200 fold increase in IHPS incidence in monozygotic twins and a 20-
fold increase in siblings or dizygotic twins [59]. A more recent genetic analysis of IHPS used a 
genome-wide association study (GWAS) to identify genomic loci associated with inherited IHPS 
[13]. By analyzing the presence of single nucleotide polymorphisms (SNPs) in 1001 individuals 
with IHPS and 2401 controls, the authors found three specific SNPs that were the most 
significantly associated with IHPS. These SNPs were located 150kbp upstream of the gene 
MBNL1, near the genes C3ORF79 and ARHGEF26, and between the genes BNIP1 and NKX2-5. 
Several other SNPs were also noted to be associated with an increased prevalence of IHPS, 
including the SNP rs2228671 on chromosome 19p13.2, which is correlated with the significant 
excess risk of IHPS in males [12, 59, 60]. However, this association could not be replicated and 
so was not further pursued. Another recent study confirmed two of the novel loci for IHPS on 
chromosomes 3 and 5 [61]. These data suggest that the genes MBNL1 and NKX2-5 are the most 
interesting targets for further study. 
 
MBNL1 is associated with postnatal splicing 
MBNL1 is one of a family of three muscleblind proteins (MBNL1-3) that were originally 
described in association with myotonic dystrophy (DM) [62, 63]. These proteins are homologues 
of the Drosophila muscleblind protein, which is required for terminal differentiation of muscle 
tissue and photoreceptors [64, 65]. Analysis of the function of these genes revealed that they are 
involved in mutant RNA accumulation in the nucleus, suggesting a role in transcription [66]. 
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Subsequent studies demonstrated that the MBNL genes are responsible for regulation of 
alternative splicing of cardiac troponin T and insulin receptor in DM [67]. These genes are also 
antagonized by the CELF proteins, which are also implicated in DM pathogenesis.  Significantly, 
both of these gene families have been implicated in alternative splicing regulation during 
postnatal cardiac development [68, 69]. During the course of cardiac development, MBNL1 
expression rises at around postnatal day 5 (PN5) [68]. This correlates with the expression of a 
subset of genes that show splicing defects in DM and are expressed between P2 and P20 [69]. As 
I mentioned earlier, IHPS incidence occurs 2-8 weeks after birth in humans. This corresponds 
closely to the timepoint at which MBNL1 is found to be critical for the regulation of DM gene 
expression. Thus, it may be that a mutation in MBNL1 that alters the expression of a downstream 
splicing target at around this time gives rise to IHPS.  
 
NKX2-5 is a marker of splenic precursor cells 
In the GWAS study, participants with a SNP found near the NKX2-5 locus were 42% more likely 
to have IHPS than controls [13]. Nkx2-5 is a homeodomain transcription factor expressed in 
several organ domains including the heart, pylorus, thyroid, and pharynx [70-72]. It is a known 
regulator of cardiomyocyte differentiation [73-75], and a marker of splenic precursor cells [76, 
77]. I will discuss its known expression in the early lateral plate mesoderm and spleen 
morphogenesis in section 4.2. Expression of Nkx2-5 at the pylorus is highly conserved in chick, 
mouse and human [78-80], and has been implicated as a regulator of epithelial morphogenesis at 
the chick pylorus (Figure 1.4, see Section 5.1). The known functions and expression domains of 
Nkx2-5 make it a promising gene for further investigation in mammalian pylorogenesis. 
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Figure 1.4 Patterning of the forgeut-midgut junction is evolutionarily conserved 
Schematics representing signaling molecule and transcription factor expression domains 
in the (A) chick, (B) mouse, and (C) human stomachs show broad conservation of 
patterning across species. In all of these model systems, Six2 and Barx1 are expressed in 
an antral domain while NKX2-5 is expressed at the pylorus. The signaling molecule 
Bmp4 is expressed in both the stomach and duodenum but is excluded from the pylorus. 
(Image modified from Smith et al. 2008 with permission from John Wiley & Sons). 
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Other implicated genes 
The other genes near the implicated loci within the GWAS study have a variety of functions not 
closely associated with muscle development. C3ORF79 is a transcript of unknown function thus, 
while it may be related to IHPS, this relationship must be explored further. ARHGEF26 encodes 
the gene SGEF, a guanine nucleotide exchange factor that has been implicated in atherosclerosis 
as factor that recruits and retains leukocytes at athero-prone sites of inflammation [81]. In 
addition, it has been associated with the promotion of prostate cancer development and 
progression [82]. Given the existing data on IHPS pathogenesis, it may be that an inflammatory 
pathway contributes to the disease. But further investigation is required to determine whether or 
not SGEF plays a role in IHPS.  
 
A locus on chromosome 19 segregates with IHPS, particularly with males [59]. The closest gene 
to this locus is a member of the YIP1 family, YIPF2. While there are no published data on this 
gene, other YIP1 family members have been described as critical regulators of vesicle 
biogenesis, that mediate association with the well known vesicle trafficking Rab proteins [83, 
84]. Loss of YIP1p leads to severe disruption of membrane transport and ER vesicle budding 
[85]. Since studies of IHPS have described alterations in endoplasmic reticulum formation and 
function [31, 42], it is possible that this gene may be involved in at least some etiologies of 
IHPS. The chromosomes on which the most highly associated loci were found were 
chromosomes 3 and 5. A microarray analysis of foregut-midgut junction genes performed by our 
lab identified several proteins that were expressed in a pyloric-specific domain [7]. Of these, the 
gene NR2C2 is expressed on human chromosome 3, about 150kb upstream of a strongly 
associated SNP [13] (Supplemental). This gene codes for the protein testicular receptor 4 (TR4), 
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an orphan nuclear receptor that is involved in a number of signaling pathways including the 
retinoic acid (RA) signaling pathway [81, 82], and the PPARα signaling pathway [83, 84]. Due 
to the heterogeneity of the upstream modulators and targets of this gene, it is difficult to 
speculate regarding its putative role in the pathogenesis of IHPS. 
 
1.5 Embryonic and fetal development of the pyloric region 
While linkage studies are providing some interesting candidate genes that might functionally 
contribute to the development of IHPS (and DGR), testing the function of those genes in mouse 
models is required in order to confirm their involvement and understand their roles. Such 
analyses in turn require a solid understanding of the development and patterning of pyloric tissue 
components. Like the rest of the GI tract, the epithelium at the pylorus is derived from endoderm 
while the underlying stroma and muscle is mesodermally derived. The composition of adult 
pyloric tissue is described above; in this section, I review the early embryonic and fetal events 
that lead to development of the pyloric muscle and its overlying epithelium. 
 
Patterning of the mammalian digestive system begins with regional expression of the Nodal 
transcription factor in a region of the early embryo called the proximal epiblast. During 
gastrulation, an endodermal fate is promoted in cells with high Nodal and mesodermal fate in 
cells with low Nodal [85]. Around E8.5, the endoderm transforms from a flat sheet to a 
cylindrical gut tube. This occurs through the formation of the anterior intestinal portal (AIP) and 
the caudal intestinal portal (CIP) which then migrate caudally and rostrally, respectively. By the 
end of this process, when the gut endoderm is a simple cylindrical tube, it is already patterned 
into broad anterior, medial, and posterior domains identified by the expression of a variety of  
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Figure 1.5 Signaling pathways in the developing mouse endoderm 
Schematic of the BMP, WNT, FGF and RA pathways in the developing endoderm shows that the 
BMP, WNT, and FGF pathways are expressed in an increasing anterior-posterior gradient. 
Conversely, inhibitors of the BMP and WNT pathways are expressed in a decreasing anterior-
posterior gradient. In contrast, the RA pathway is expressed in an increasing gradient that peaks 
at the midgut and decreases again toward the posterior hindgut. (Image reprinted from Spence et 
al. 2011 with permission from John Wiley & Sons).  
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transcription factors including Sox2, Pdx1, and Cdx2. These transcription factors are critical in 
the establishment of the foregut-midgut boundary. 
 
A variety of signaling pathways are involved in endodermal organogenesis, including Hedgehog, 
Bmp, Wnt, Fgf, and RA signaling pathways (Figure 1.5; [85-91]). The expression of each of 
these transcription factors is domain specific and they work in concert to establish the precise A-
P pattern of the gut and its associated organs. During foregut specification, high Fgf induces  
Nkx2-1 expression in the trachea and lung progenitors, moderate Fgf induces Albumin in liver 
progenitors, while low Fgf induces Pdx1 expression in pancreatic progenitors [91]. This gradient 
is similar in direction and function to that of the signaling molecule Bmp. During this time, RA 
signaling is also necessary for the establishment of foregut fates. Raldh2 null mice fail to develop 
foregut organs including the lungs, stomach, and dorsal pancreas [92]. RA appears to function 
both independently through Hox genes and through downstream effectors including the Fgf and 
Hh pathways [86].  
 
1.5.1 Foregut/Midgut Organ domains in the epithelium 
The broad foregut-midgut boundaries formed during early embryogenesis are necessary for the 
organ-specific patterns that arise in mid to late development. In the epithelium, SOX2 expression 
is induced throughout the foregut region and has been shown to be necessary for the formation of 
both the esophagus and lungs. Specifically, severe Sox2 hypomorphs develop a variety of 
tracheoesophageal fistulas with proximal esophageal atresia [93]. Similarly, expression of Cdx1 
and Cdx2 are important for the specification of intestinal epithelium. Loss of Cdx2 leads to 
anteriorization of the intestinal epithelium, with a stronger phenotype with compound deletion of 
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both Cdx1 and 2 [94].  This process leads to the expression of anterior endodermal markers in the 
intestine, including the genes Sox2 and Barx1, the latter of which is involved in defining the 
gastric phenotype [95], and will be discussed in detail in section 5.2. 
 
The pylorus actually forms at the boundary between the stomach and duodenum (marked early 
on by the boundary of the Sox2 and Cdx2 domains in the epithelium). Interestingly, Pdx1, a 
paired family homeobox protein, is expressed in the epithelium of the distal stomach (antrum), 
pylorus and proximal duodenum.  Pdx1 is known to be important for pancreas development and 
its loss leads to failure of the pancreatic anlag to develop [96]. Additionally, loss of Pdx1 causes 
dysmorphology of the pylorus [97], though the pathological picture has not been well described 
either histologically or molecularly. 
 
1.5.2 Foregut/Midgut Organ domains in the mesenchyme 
The formation of the mesenchymal investment at the pylorus is an interesting and dynamic 
process. Specification of the pyloric mesenchyme begins with the creation of the left-right (LR) 
asymmetry in the lateral plate mesoderm (LPM) that is initiated by Nodal signaling [76, 98, 99]. 
The signaling molecules that regulate this asymmetry, including Shh, Fgf-8, and Bmp, are well 
described [98, 99], but we are only recently beginning to understand the transcription factors that 
transduce this signal to the tissues themselves. 
 
Nkx2-5 is expressed in the LPM, initially bilaterally, and later predominantly on the left in the 
area of the dorsal pancreas outgrowth. This expression domain also marks the site of splenic and 
pyloric precursor cells [76, 100]. Nkx2-5 is a homeodomain protein that is known to be involved 
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in cardiomyocyte differentiation; loss of Nkx2-5 leads to embryonic lethality at E11.5 due to a 
loss of cardiac looping [101]. Nkx2-5 expression in the LPM is obvious by E9.5 in two distinct 
domains that flank the dorsal pancreatic bud [76, 77]. This expression overlaps that of another 
known splenic gene, Hox11, demonstrating that this is truly splenic precursor tissue [76]. Since 
this LPM tissue gives rise to both the pancreas and the spleen, it is termed the splenopancreatic 
mesenchyme. The region abutting the splenopancreatic mesenchyme on the left side of the 
mouse is termed the splanchnic mesodermal plate (SPM). 
 
By E10, Nkx2-5 expression has solidified into a single, continuous domain with the right and left 
sides connected dorsally [77]. The presumptive pyloric sphincter forms in this area and, by 
E10.5, Nkx2-5 expression is obvious in the pyloric mesenchyme. By E12.5, the Nkx2-5 positive 
cells in the region of the pylorus give rise to a stream of cells that then form an elongated 
structure along the A-P axis of the stomach: the future spleen. The cellular stream between the 
pylorus and the spleen continues to express Nkx2-5 until around E14.5, when the spleen and 
pylorus form two distinct regions of Nkx2-5 expression [77]. The further expression and function 
of Nkx2-5 at the pylorus will be discussed in section 5.1 and 5.2.  
 
1.5.3 Bapx1 is necessary for proper formation of the splenopancreatic mesenchyme 
At E10.5, the homeodomain protein Nkx3-2 (Bapx1) is also expressed in an asymmetric pattern 
in the SPM [106], along with the gastric gene Barx1 [76]. Bapx1 null embryos are asplenic, 
suggesting that this early expression is critical for spleen formation. Interestingly, loss of Bapx1 
also results in the dorsal pancreatic bud growing at the midline, instead of laterally as it normally 
does, suggesting that loss of Bapx1 leads to dysfunction of the entire splenopancreatic 
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mesenchyme. Indeed asplenic mouse models generally show a marked disruption of the gastric 
lobe of the pancreas [104, 107]. 
 
1.6 Pyloric gene expression 
As described above, development of the pyloric domain is a complex process involving 
overlapping expression domains of a variety of signaling and transcription factors. Once the 
pylorus is morphologically distinct, a number of genes are expressed in a pylorus-specific 
pattern, including Bmp4, Nkx2-5, Sox9, Barx1, and Six2. Studies from our lab have identified a 
variety of other genes that are expressed uniquely at or around the pylorus [7], but the ones listed 
above are the best characterized of that set. Here, I will describe their expression and summarize 
their known functions at the pylorus.  
 
1.6.1 Gene expression in the chick pylorus 
Our current understanding of pyloric signaling is largely based on early work in the chick 
embryo. In the chick, the pylorus is the junction between the gizzard (homolog of the antrum) 
and the duodenum. Placement, and perhaps formation of the pyloric muscle in the chick appears 
to be regulated by expression of the signaling factor Sonic Hedgehog (Shh) [79], which activates 
expression of its target, Bmp4 [78, 79, 102]. Bmp4 is a member of the TGF-β family of signaling 
molecules which are critical for differentiation and patterning in a variety of organ systems. 
Bmp4 expression is apparent in the gut tube as soon as E2.5 in the chick embryo (about E8 in the 
mouse embryo). Interestingly, Bmp4 expression appears to be excluded from the region that will 
form the pyloric sphincter [102]. However, several BMP receptors are expressed at the pylorus 
throughout this time, with Bmpr1b specifically expressed in the developing gizzard mesoderm 
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[78, 79, 102]. Earlier studies demonstrated that ectopic expression of Bmp4 in the gastric region 
leads to decreased mesenchymal muscular thickness [103]. Similarly, viral misexpression of 
Bmp4 at the pylorus interferes with muscle development, decreases mseodermal proliferation and 
increases apoptosis. In addition, ectopic expression of Bmp4 at the pylorus leads to expansion of 
the expression domains of both Nkx2-5 and Sox9, suggesting that these genes are BMP targets at 
the pylorus [78].  
 
NKX2-5 is expressed in a narrow band at the pylorus beginning at least as early as E12.5 [78-
80]. Pyloric expression of Nkx2-5 appears to be regulated by Bmp4 and in the chick, the function 
of Nkx2-5 seems to be specification of the morphology of the overlying pyloric epithelium [78]. 
When Nkx2-5 is misexpressed in the chick gizzard, the overlying gizzard epithelium changes 
character, and becomes similar to pyloric epithelium [78]. Loss of Nkx2-5 does not alter pyloric 
epithelial morphology, but causes secretion of koilen, a keratin-like substance that is 
characteristic of the gizzard, into the pyloric lumen; thus, its loss partially transforms the pyloric 
epithelium to gizzard epithelium [5, 78]. Neither overexpression or loss of Nkx2-5 in the chick 
model has any apparent effect on the mesenchymal tissues, including the muscle.  
 
Like Nkx2-5, Sox9 appears to control epithelial character. In the absence of pyloric Sox9, the 
pyloric epithelium adopts a gizzard-like phenotype and ectopic expression of Sox9 in the gizzard 
transforms epithelium to a pylorus-like phenotype [5, 78]. Gremlin1 has been identified as a 
downstream target of Sox9; loss of Grem1, like loss of Sox9, alters the pyloric epithelium, 
making it gizzard-like [5]. While both Nkx2-5 and Sox9 are known Bmp4 targets at the chick 
pylorus, they do not appear to regulate each other in that model. Importantly, there is no 
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evidence in the chick system to connect either Sox9 or Nkx2-5 to pyloric muscular development 
or function. 
 
1.6.2 Gene expression in the mouse pylorus 
More recent studies have expanded on earlier descriptions of signaling molecules and 
transcription factors at the mouse pylorus. In particular, a series of studies have implicated the 
known posterior stomach markers Barx1, Nkx2-5 and Six2 in pyloric muscular development. In 
addition, subsequent studies have shown that genes involved in spleen development, like Bapx1, 
are also involved in pyloric patterning. Here I will summarize the known findings on mouse 
mammalian pyloric development and tie these findings into a larger signaling framework (Figure 
1.6). 
 
Barx1 regulates antral patterning 
Earlier I discussed the role of Barx1 in the establishment of gastric mucosa in heterotopic lesions 
in Cdx2 chimera [104]. Barx1 is a foregut mesenchymal homeobox transcription factor that is 
expressed throughout development. In Barx1 null mice, the stomach is shrunken and malformed, 
with defects in epithelial differentiation and morphogenesis [95, 105]. By E12.5, there appears to 
be heaped, undifferentiated epithelium and Cdx2 expression is obvious in the antral epithelium, 
where it is normally not seen. Loss of Barx1 also decreases expression of the WNT inhibitors 
secreted frizzled related proteins (sFRP) 1 and 2, suggesting that WNT inhibition is important in 
normal stomach development. Indeed, Axin2 expression is obvious throughout the developing 
stomach in Barx1 null embryos. At the pylorus, the constriction that is normally present between 
stomach and duodenum and marks the position of the pyloric sphincter, is missing. Interestingly, 
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Figure 1.6 Pyloric Signaling network 
This schematic of the pyloric signaling network shows two overlapping expression domains: the 
pyloric domain (purple) and the antral domain (green). The former is the site of mesenchymal 
expression of Nkx2-5, Sox9 and Grem1, which have all been shown to be downstream of Bmp4 
in the chick model. The antral domain is the site of expression of Six2, Barx1, and Bapx1, 
Signaling relationships are summarized from [5, 78, 80, 105, 108]. 
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though the spleen does not express Barx1, this organ is mislocalized and hyperplastic in the Barx 
null animals. This may well reflect the dependence of the spleen on proper pyloric patterning. 
 
Bapx1 is downstream of Barx1 in pyloric muscular patterning 
Bapx1 is a homeodomain protein that was earlier discussed in relation to the formation of the 
LPM [76]. It is also known to regulate gizzard mesenchymal patterning and development [106]. 
In the mouse, Bapx1 (also known as Nkx3-2) is expressed in the mesenteries, midgut 
mesenchyme and splenic primordium [107] during development. This expression refines to the 
muscular layers of the GI tract and the mesenteries in the adult mouse. Bapx1 null embryos lack 
spleens, and show malformations of the pyloric sphincter. There is a significant loss of 
constriction with some shape change and loss of thickness in the overlying muscularis 
mesenchyme [107, 108]. The epithelium and neuronal layers are unchanged in the absence of 
Bapx1, suggesting a specific role in muscular development.   
 
Bapx1 appears to be downstream of Barx1. Both Barx1 and Bapx1 are coexpressed in the antral 
mesenchyme with Barx1 expression extending throughout the stomach. When Barx1 is deleted 
within the Bapx1 domain, the phenotype is identical to that seen in the absence of Bapx1. 
Interestingly, loss of Bapx1 does not appear to change the expression of the midgut transcription 
factors Nkx2-5 (in pyloric mesenchyme) or Pdx1 (in epithelium). 
 
Six2 is necessary for pyloric constriction 
The transcription factor Six2 also has a conserved antral expression across several different 
species [1, 80]. Six2 null embryos exhibit a distinct loss of pyloric muscle and absence of pyloric 
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constriction throughout development. Though both the OLM and ICM are present in Six2 null 
embryos, neither muscle layer displays its characteristic pyloric expansion by E18.5. Six2 also 
appears to affect BMP signaling as well as Nkx2-5 and Sox9 expression at the pylorus. In the 
absence of Six2, Bmp4 expression expands into the pyloric region, from which it is typically 
absent. In contrast, Nkx2-5 and Sox9 expression appear to be significantly reduced and absent, 
respectively, in Six2 null mice, though the reduction in Nkx2-5 expression seems to be temporary 
[80]. Loss of Six2 also leads to a decrease in pyloric Gremlin expression, which is expected if 
Grem1 is a target of Sox9 [5]. Given that these findings contrast with those in the chick pylorus 
regarding the relationship between Bmp4, Nkx2-5, Sox9 and Grem1, this would either suggest 
that the relationship between those genes is different in the mammalian pylorus, or that Six2 is 
involved in contrasting ways in different parts of that signaling cascade. Thus, the position of 
Six2 in the pyloric signaling cascade is currently unclear.  
 
Canonical WNT signaling induces loss of pyloric constriction 
Studies on the function of Barx1 and Bapx1 demonstrated that WNT signaling is intrinsically 
linked to gastric patterning [95, 105]. However, those studies did not definitively demonstrate 
that inhibition of WNT signaling is directly involved in that patterning process. A subsequent 
study demonstrated that induction of WNT signaling does indeed lead to alterations in pyloric 
mesenchymal development reminiscent of those seen in the absence of Bapx1 [109]. 
Specifically, ectopic expression of WNT9b or a stabilized β-catenin protein in the antral Six2 
expression domain leads to a loss of pyloric constriction and decreased muscular thickness. In 
addition, ectopic WNT signaling increases NKX2-5 expression while decreasing the expression 
of Grem1 and the transcription factor Gata3. That NKX2-5 and Grem1 expression respond 
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oppositely contrasts with earlier findings in the chick pylorus and in the Six2 knockout mouse, 
where these genes are modulated in concert [78, 80]. These findings also contrast sharply with 
those seen in the Barx1 and Bapx1 null models, where NKX2-5 expression appears unaffected 
even after perturbations to the WNT pathway [105, 108]. The underlying basis for the different 
results in these two models is unclear. 
 
GATA3 is a novel pyloric transcription factor 
Work from our lab was the first to identify the expression of the Gata family transcription factor 
Gata3 at the pylorus [7]. Before this study, Gata3 had been described in a number of different 
tissues throughout the body, including skin, blood, eye, CNS, mammary glands, and adrenal 
glands [110-117]. While its specific function within these tissues varies, it is broadly required for 
differentiation and tissue specification in all of these systems. At the pylorus, the function of 
Gata3 was unclear when I began my studies. However, it appears to be expressed in the pyloric 
mesenchyme and is inhibited by ectopic pyloric expression of canonical WNTs [109].  The work 
presented in this thesis will expand on the current understanding of the expression and function 
of Gata3 at the mouse pylorus. 
 
1.6.3 Conflicts between the mouse and chick pyloric signaling models 
As I summarized above, the expression domains of several pyloric transcription factors and 
signaling molecules are well known in both the mammalian and avian models [78-80, 102, 106]. 
However, these models have demonstrated different, even conflicting results in pyloric signaling 
[78-80]. Specifically, in the chick pylorus, BMP has been shown to signal downstream to Nkx2-5 
and Sox9 [5, 78], which both regulate the character of pyloric epithelial microarchitecture [78]. 
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In addition, in the chick pylorus, Sox9 appears to perform its function through the BMP signaling 
modulator Grem1, which also regulates pyloric epithelial morphogenesis [78]. In contrast, the 
mouse Six2 knockout model appears to show that BMP, Nkx2-5 and Sox9 are altered in opposite 
directions, with loss of Six2 leading to increased Bmp4 expression but decreased Nkx2-5 and 
Sox9 expression. While it may be that Six2 regulation of these genes is complex and 
interconnected, it may also be that gene expression and function at the chick pylorus differs from 
that at the mouse pylorus. The work presented in Chapter 2 will clarify the relationship between 
Nkx2-5 and Sox9 and establish the function of Nkx2-5 in pyloric development.  
 
1.7 Expanding the State of the Field 
Though it is clear that multiple proteins and signaling factors are needed for the proper formation 
of the pylorus, it is striking that the vast majority of the published work used either Q-RT-PCR 
or whole mount in situ hybridization to follow the expression of genes after deletion or 
overexpression of candidate regulators. Thus, it had not been determined which of the multiple 
factors are actually expressed in the same cell. Indeed, even the identities of the cells that express 
each transcription factor were unknown at the time that I started these studies. Additionally, as 
pointed out above, there were major discordancies among the various published studies both with 
regard to the actual signaling cascades required for pyloric development and with regard to the 
function of each factor (e.g., regulation of epithelial character or muscular development). My 
goal in this thesis was first to clarify both the expression and the function of some of the major 
regulators of pyloric development. Nkx2-5 was prioritized because of its genetic association with 
IHPS [13] and Gata3 was prioritized because it was a novel pyloric-specific gene first identified 
by studies from our laboratory [7]. In the following chapters, I will present data that clarifies 
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pyloric development and shows for the first time that a specific fascicle of outer longitudinal 
muscle can play a major role in pyloric sphincter development. I will also explain how these 
findings extend our current understanding of both the pyloric signaling cascade and the 
etiologies of the pyloric pathologies DGR and IHPS.  
 
Establishment of the domains of both Gata3 and Nkx2-5 expression led to a serendipitous finding 
that I pursued in Chapter 3.  Specifically, I found that both proteins are expressed in a pair of 
bilateral superficial cords on the ventral surface of the stomach; these structures had been 
previously defined as gastric ligaments. Further investigation revealed that they are smooth 
muscle structures that are continuous with the outer longitudinal muscle. Chapter 3 provides the 
first molecular and cellular characterization of these structures, which we have renamed “pyloric 
ligaments”. Finally, in Chapter 4, I will conclude with an examination of the open questions 
remaining within the field, particularly those that arise as a consequence of this work, and will 
propose further experimentation to expand upon the presented work.   
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Chapter 2 1 
The role of Gata3 and Nkx2-5 in pyloric development 
Summary 
Background & Aims: Infantile hypertrophic pyloric stenosis (IHPS) is a common birth anomaly 
characterized by narrowing of the pyloric lumen. A recent genome wide association study 
implicated NKX2-5, a gene encoding a transcription factor that is expressed in embryonic heart 
and pylorus, in the pathogenesis of IHPS.  However, the function of the NKX2-5 protein in 
pyloric smooth muscle development has not been directly examined. Hence, our goals were to: a) 
define the pattern of Nkx2-5 expression during the course of murine pyloric sphincter 
development; b) examine co-expression of Nkx2-5 with Gata3 and Sox9, two other transcription 
factor genes that display pyloric-specific mesenchymal expression domains; and, c) assess 
pyloric sphincter development in the absence of Nkx2-5 or Gata3. 
 
Methods: Cellular domains of NKX2-5, GATA3, and SOX9 expression were determined by 
immunofluorescence. Pyloric development was assessed in mice with conditional or germline 
deletion of Nkx2-5 or Gata3, respectively. 
 
Results: Gata3, Nkx2-5, and Sox9 are co-expressed in differentiating smooth muscle cells of a 
distinct fascicle of the pyloric outer longitudinal muscle (OLM). Expansion of this fascicle 
                                                 
1 This text is from a submitted manuscript. The contributing authors are: Aaron M. Udager*, Ajay Prakash*, David 
A. Saenz, Martina Schinke, Takashi Moriguchi, Patrick Y. Jay, Kim-Chew Lim, James Douglas Engel, and Deborah 
L. Gumucio  [The first two co-authors made equal contributions to the work.] 
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coincides with development of the pyloric sphincter. Absence of Nkx2-5 or Gata3 causes severe 
hypoplasia of this fascicle and alters pyloric muscle shape. While Sox9 expression requires both 
Nkx2-5 and Gata3, there is no apparent hierarchical relationship between Nkx2-5 and Gata3 
during pyloric OLM development. 
 
Conclusions: Nkx2-5 and Gata3 are independently required for the development of a pyloric 
OLM fascicle that plays a critical role in pyloric sphincter morphogenesis. These data predict 
that regulatory changes that alter Nkx2-5 or Gata3 expression could play a role in IHPS 
pathogenesis. 
 
2.1 Introduction 
The pyloric sphincter integrates neuronal and hormonal signals to control the movement of food 
from the stomach to the small intestine [118]. This sphincter is clinically significant in the 
context of the common human congenital pathology, infantile hypertrophic pyloric stenosis 
(IHPS), in which both the structure and function of the sphincter are abnormal[9, 24, 119]. 
Infants with IHPS classically present three to six weeks after birth with projectile vomiting, as 
well as physical and radiographic findings of gastric outlet obstruction. The etiology of IHPS 
appears to be complex and may involve both environmental and genetic factors; changes in 
musculature, mucosa, extracellular matrix, nerve conduction, and nitric oxide signaling have all 
been implicated in IHPS pathogenesis[9, 24, 119]. 
 
A recent genome-wide association study (GWAS) in humans identified several IHPS 
susceptibility loci, including the homeodomain transcription factor NKX2-5[13]. This is of 
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interest because Nkx2-5 is expressed in pyloric mesenchyme during embryogenesis in frog, 
chick, and mouse[1], although the precise identity of the expressing cells is unknown. Despite its 
evolutionarily conserved pyloric expression and association with IHPS, the role of Nkx2-5 in 
pyloric development has not been examined in vertebrate models, in part because Nkx2-5 null 
mice die of cardiac abnormalities at E10[120], well before the pyloric region is fully developed. 
 
Work in the chick model suggests that BMP signaling controls the expression of both Nkx2-5 
and the SRY-related, HMG-box gene Sox9[5, 78, 79, 102]. Functionally, loss of either Nkx2-5 or 
Sox9 expression in the chick affects the character of the pyloric epithelium but has no effect on 
the pyloric musculature[5, 78, 79, 102], suggesting that these mesenchymal factors act indirectly 
to control the expression of an unknown modulator of epithelial phenotype. 
 
In the mouse, direct functional analysis of Nkx2-5 or Sox9 at the pylorus has not been reported; 
however, other genetic models of pyloric sphincter dysmorphogenesis have been described[80, 
105, 107-109]. For example, germline deficiency of Six2, a homeodomain transcription factor 
expressed in the posterior stomach, abrogates Sox9 expression and temporarily reduces Nkx2-5 
expression at the pylorus, though this expression is later recovered[80]. Importantly, in Six2 
mutant mice, the pyloric musculature and its corresponding luminal constriction are highly 
attenuated, indicating that Six2 and/or one or more of its downstream targets is important for 
pyloric sphincter development. 
 
Though a role for Nkx2-5 in the formation of the pyloric sphincter might be inferred from the 
phenotype of Six2 null mice, a direct connection between Nkx2-5 and sphincter muscle 
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development has not been demonstrated in either the mouse or chick models. In fact, while it is 
clear from previous studies that Nkx2-5 is expressed in pyloric mesenchyme, we present here the 
first analysis of its expression at the cellular level during pyloric sphincter development and 
correlate this expression pattern with development of the sphincter muscles. 
 
We find that NKX2-5 protein is expressed in myofibroblasts and smooth muscle cells of the 
pylorus. NKX2-5 expression is most robust in a dorsal fascicle of outer longitudinal muscle 
(OLM) that matures between embryonic days (E) 14.5 and 16.5. Interestingly, the cells of this 
OLM fascicle also express SOX9, as well as GATA3, a zinc finger transcription factor that we 
previously identified as a pylorus-specific gene[7]. After germline deletion of Gata3 or 
conditional deletion of Nkx2-5, the dorsal pyloric OLM fascicle is hypoplastic, the shape of the 
inner circular muscle (ICM) is altered and constriction of the pyloric sphincter is attenuated. 
Together, these data reveal a distinct transcriptional regulatory cascade that is used for 
development of the dorsal pyloric OLM; correct development of this fascicle is required to 
generate the proper morphology of the pyloric sphincter. These findings have implications for 
the potential role of NKX2-5 in the pathogenesis of IHPS in humans. 
 
2.2 Materials and methods 
 
Mice 
All protocols for mouse experiments were approved by and carried out in accordance with the 
policies of the University of Michigan University Committee of Use and Care of Animals and 
Unit for Laboratory Animal Medicine. C57BL/6J inbred (“wild type”) mice were obtained from 
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Charles River Laboratories (Wilmington, MA). The generation of Gata3lacZ/+, Nkx2-5lacZ/+ and 
CAGGCre-ERTM mice has been described previously[117, 121, 122]. 
 
Gata3 null embryos were generated via Gata3lacZ/+ intercrosses. To escape early embryonic 
lethality, Gata3 null embryos were pharmacologically rescued in utero by treating timed-
pregnant dams with α- and β-adrenergic agonists, as previously described[110, 113]. The rescue 
solution was administered once daily, beginning at E7.5, and all other drinking water was 
withheld. Rescue solution was prepared fresh, as follows: 15 mg each of isoproterenol (Sigma-
Aldrich, St. Louis, MO, I-5627) and phenylephrine (Sigma-Aldrich, P-6126) was added to 50 
mL of water and supplemented with 100 mg of ascorbic acid and 2 g of sucrose. 
 
Nkx2-5flox/+ mice were generated by targeted homologous recombination in embryonic stem 
cells, as described previously[123, 124]. The targeting construct was created by cloning a 
neomycin resistance cassette, flanked by FLP recognition target (FRT) sites, into intron 1 of 
Nkx2-5; loxP sites were then cloned upstream of the neomycin resistance cassette and 
downstream of the homeodomain-containing exon 2 (Figure 2.1B). The neomycin resistance 
cassette was excised via FLP-mediated FRT site recombination, resulting in loxP sites flanking 
exon 2 (Figure 2.1C). Nkx2-5flox/+ mice were crossed to CAGGCre-ERTM (The Jackson 
Laboratory, Bar Harbor, ME, 004682) and bred to homozygosity for the conditional allele 
(CAGGCre-ERTM;Nkx2-5flox/flox). Inactivation of Nkx2-5 in timed-pregnant dams was 
accomplished via once-daily intraperitoneal injections of tamoxifen (3 mg in 150 μL of corn oil; 
Sigma-Aldrich, T5648), as described previously[121]. 
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Figure 2.1 Generation of a conditional Nkx2-5 allele. 
Illustration of the gene targeting approach used to produce a conditional Nkx2-5 allele. A) The 
wild type Nkx2-5 locus contains two exons. B) The targeting vector contains a neomycin 
selection cassette with flanking FRT sites in intron 1; flanking loxP sites are located between the 
FRT/neomycin sequences and exon 1 and outside (downstream) of exon 2. C) After homologous 
recombination in ES cells (“Targeted Locus”), FLP recombinase removed the neomycin cassette, 
producing the Nkx2-5 conditional allele (Nkx2-5flox), which has loxP sites flanking exon 2 and 
a single FRT site in intron 1 (“Flp Recombined Locus”). In cells that express Cre and Nkx2-
5flox, the loxP sites recombine, and the intervening sequence (including the homeodomain-
containing exon 2) is deleted (“Cre Recombined Locus”); this generates a truncated Nkx2-5 
transcript, which does not produce a stable detectable NKX2-5 peptide (see Figure 2.11Biii). 
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Genotyping 
Genomic DNA for genotyping was extracted from adult tail or embryonic tissue by proteinase K 
digestion with high-salt ethanol precipitation. Genotyping was performed using standard PCR 
methods with sequence-specific primers and agarose gel electrophoresis. 
 
Histology 
Staged E14.5-E18.5 embryos from litters of timed-pregnant dams were dissected on ice in 1X 
PBS. Excised gastrointestinal tracts were fixed overnight at 4°C in 4% paraformaldehyde (PFA), 
embedded in paraffin, cut into 5-10 μm sections with a microtome, and adhered to Superfrost 
Plus glass slides (Fisher Scientific, Hampton, NH, 22-034-979).  
 
Hematoxylin and eosin (H&E) staining 
For H&E staining, standard laboratory methods were used. Briefly, sections were deparaffinized 
in xylene, rehydrated through decreasing alcohol concentrations, stained with hematoxylin, 
incubated in bluing solution, counterstained with eosin, dehydrated through increasing alcohol 
concentrations, and equilibrated with xylene. Glass coverslips were mounted with Permount 
(Fisher Scientific, SP15-100). Sections were photographed with an E800 microscope (Nikon, 
Tokyo, Japan) and Spot CCD camera (Diagnostic Instruments, Sterling Heights, MI). 
 
Immunofluorescence 
Sections were deparaffinized in xylene, and rehydrated through decreasing alcohol 
concentrations. For antigen retrieval, sections were boiled for 10 minutes either in 10 mM 
sodium citrate, pH 6.0, or Antigen Unmasking Solution, Citric Acid Based (Vector Laboratories, 
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Burlingame, CA, H-3300). Sections were then blocked with 10% animal serum/0.01% Triton X-
100 in 1X PBS (“blocking solution”) for 30 minutes at room temperature. Primary antibodies, 
diluted in blocking solution, were incubated on sections (duration dependent on specific 
antibody). Sections were washed in 1X PBS prior to incubation with appropriate secondary 
antibodies (diluted in blocking solution) for 30 minutes at room temperature. For signal 
amplification, slides were washed in 1X PBS and incubated with appropriate tertiary antibodies 
(diluted in blocking solution) for 30 minutes at room temperature. αSMAimmunofluorescence 
was performed by incubating sections with Cy3-conjugated primary antibody at room 
temperature for 30 minutes, either independently after antigen retrieval or during incubation with 
secondary or tertiary antibodies. Glass coverslips were mounted with ProLong Gold Antifade 
Reagent with DAPI (Life Technologies, Carlsbad, CA, P-36931). Sections were photographed 
with an Apotome microscope (Carl Zeiss AG, Jena, Germany) and AxioCam MR camera (Carl 
Zeiss). 
 
Primary antibodies used were: Cy3-conjugated, mouse monoclonal to αSMA (1:500; Sigma-
Aldrich, C6198); goat polyclonal to NKX2-5 (1:100; Santa Cruz Biotechnology, Santa Cruz, 
CA, sc-8697); mouse monoclonal to GATA3 (1:50; Santa Cruz Biotechnology, sc-268); rabbit 
polyclonal to SOX9 (1:200; Millipore, Dramstadt, Germany, AB5535); rabbit monoclonal to 
Cleaved Caspase-3 (1:200; Cell Signaling, Danvers, MA, 9664S); rat polyclonal to BrdU (1:200; 
Accurate Chemical & Scientific, Westbury, NY, OBT0030G); and, rabbit polyclonal to 
Peripherin (1:200; Millipore, AB1530). Secondary antibodies used were: biotinylated horse anti-
mouse IgG (1:200; Vector Laboratories, BA-2000); 488 donkey anti-rat IgG(1:100; Life 
Technologies, A-21208); 488 donkey anti-rabbit IgG (1:100; Life Technologies, A-21206); and 
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APC-conjugated donkey anti-goat IgG (1:100; Jackson ImmunoResearch, West Grove, PA, 703-
136-155). Tertiary antibodies used were: Cy3/FITC/Cy5-conjugated mouse monoclonal to biotin 
(1:200; Jackson ImmunoResearch, 200-162-211/200-092-211/200-172-211).  
 
Cdx2 immunohistochemistry 
Paraffin sections were processed as described above (see Immunofluorescence). Primary mouse 
monoclonal antibody to Cdx2 (1:200; BioGenex, San Ramon, CA; MU392A-UC) was diluted in 
blocking solution and incubated on sections overnight at 4ºC. Sections were washed in 1X PBS 
prior to incubation with a biotinylated horse pan-specific secondary antibody (1:1000; Vector 
Laboratories, BA-1300) and ABC reagent (Vectastain ABC Kit; Vector Laboratories, PK-6100), 
each for 30 minutes at room temperature. Sections were then processed using the DAB 
peroxidase substrate kit (Vector Laboratories, SK-4100), counterstained with H&E, and mounted 
under glass coverslips with Permount. Sections were photographed as described above (see H&E 
staining). 
 
BrdU labeling 
A single intraperitoneal injection of BrdU (20 μg/g body weight in 1 mL of 1X PBS; Life 
Technologies, B23151) was administered to timed-pregnant dams, two hours prior to sacrifice; 
harvested embryos were then dissected and analyzed as described above. 
 
Immunofluorescence quantitation 
Four, five, or six total sections from three independent WT and Nkx2-5 conditional null embryos 
were examined by double immunofluorescence for Nkx2-5 and Casp3 or BrdU, as described 
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above (see Immunofluorescence). Sections were photographed using the same exposure settings 
for each channel (DAPI, FITC, and Cy3), and the fluorescence in each channel was depicted as a 
single color (red). For each section, one investigator (A.P.) used the DAPI channel to define an 
area for examination, denoted by a white line in all four channel images, and counted the total 
number of nuclei. A.P. then randomly assigned numbers to each section, blinding the genotype 
for another investigator, who counted the number of discrete fluorescent signals (Tables  2 and 
3). Cell number and percentage of total cells were analyzed by the Student’s t-test statistic in 
Excel (Microsoft, Redmond, WA; unpaired, heteroscedastic). 
 
Measurement of pyloric sphincter constriction 
A single section from at least three independent WT, Gata3 deficient, and Nkx2-5 conditional 
null embryos was examined by immunofluorescence for αSMA, as described above (see 
Immunofluorescence). The shortest distance between the smooth muscle (ICM) layers on 
opposite sides of the pyloric lumen was measured with ImageJ (United States National Institutes 
of Health, Bethesda, MA)1. The measurements were averaged and analyzed by the Student’s t-
test statistic in Excel (as described above). 
 
Whole mount X-gal staining 
Staged Gata3lacZ/+ or Nkx2-5lacZ/+ embryos were dissected on ice in 1X PBS. The stomach 
and adjoining duodenum was excised, fixed with 4% PFA for 10 minutes at 4°C, and washed 
well in 1X PBS. X-gal staining solution was prepared fresh, as follows: 1X PBS (pH 7.5), 2 mM 
magnesium chloride, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, and 1 mg X-
gal (from 20 mg/ml stock in DMF; Life Technologies, 15520-04). Fixed tissue was incubated in 
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staining solution at 37°C and monitored periodically to control staining intensity. Stained tissue 
was washed well in 1X PBS and then post-fixed overnight at 4°C in 4% PFA. Whole mount 
tissue was photographed in 1X PBS or 80% glycerol (in 1X PBS) with a Leica MZ12.5 
dissecting microscope (Solms, Germany) and Spot CCD camera. 
 
2.3 Results 
 
Development of pyloric muscular components 
Despite the important function of pyloric sphincter, development of its smooth muscle 
components has not been assessed at the cellular level. We therefore examined sectioned pyloric 
tissue using H&E staining and immunofluorescence for alpha smooth muscle actin (αSMA), a 
marker of differentiated smooth muscle cells and myofibroblasts. At E14.5, the ICM at the 
pylorus is contiguous with that of the surrounding stomach and intestine and strongly expresses 
αSMA (Figure 2.2A-B). In contrast, the nascent OLM contains a thin layer of weakly positive 
αSMA positive cells (Figure 2.2Bv,vi, asterisk).  These cells are not yet tightly organized into 
muscular bundles. Dorsally, these cells bridge directly to and intermingle with a prominent 
collection of αSMA negative pancreatic mesenchymal cells (Figure 2.2Aii, PM). 
 
By E16.5, the pyloric OLM is compacted and robustly expresses αSMA, indicative of smooth 
muscle differentiation (Figure 2.2C-D). Dorsally, a thickened fascicle of OLM appears to 
displace the ICM internally (Figure 2.2Dv,vi, asterisk), thereby narrowing the pyloric lumen to 
generate the characteristic constriction of the mature pyloric sphincter. 
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Figure 2.2 Development of the pylorus between E14.5 and E16.5 involves differentiation of the 
dorsal OLM and changes in ICM shape. 
H&E staining of WT pylorus at (A) E14.5 or (C) E16.5; the dorsal pylorus, within the boxed 
region in (i) is enlarged in (ii). Immunofluorescence of the dorsal WT pylorus at (B) E14.5 or 
(D) E16.5: (i,iv) DAPI; (ii,v) αSMA; or (iii,vi) merged. (A-B) Though the ICM is well-
differentiated and strongly αSMA positive at E14.5, cells of the OLM stain weakly for αSMA 
(asterisk in Bvi). (A-B) Expansion and differentiation of the OLM (asterisk in Dvi) is associated 
with an increase in αSMA expression and inward displacement of the ICM, resulting in pyloric 
sphincter constriction. For all images, stomach (S) is left; duodenum (D) is right; and, dorsal is 
top. Green lines mark the epithelial basement membrane, and white lines separate ICM and 
OLM. E = epithelium; SM = sub-epithelial mesenchyme; and, PM = pancreatic mesenchyme. 
Scale bars represent 100 µm. 
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Nkx2-5 and Gata3 are expressed in similar domains at the pylorus 
 
Previous studies have shown that, as early as E9.5, a mesenchymal Nkx2-5 expression domain 
surrounds the nascent distal stomach and proximal duodenal endoderm[25]. By E12.5, some 
cells within this mesenchymal domain have migrated anteriorly along the left (dorsal) side of the 
stomach to give rise to the spleen, while others remain at the pylorus[25]. Since the late 
embryonic expression pattern of Nkx2-5 at the pylorus has not been carefully described, we 
examined whole mount X-gal staining of dissected tissue from Nkx2-5lacZ/+ embryos. At E14.5, 
Nkx2-5-expressing cells encircle the pylorus and staining on the dorsal side of the pylorus 
extends into adjoining pancreatic mesenchyme (Figure 2.3Ai). Bilateral cellular cords, 
emanating from the pylorus and reaching across the lesser curvature of the antrum, also express 
Nkx2-5 (Figure 2.3Ai, black arrowheads); these structures likely correspond to the previously 
described gastric ligaments[125]. Continuity between the X-gal positive pyloric band and gastric 
ligaments is obvious ventrally (Figure 2.3Aii). Between E14.5 and E18.5, the gastric ligaments 
lengthen to reach the gastro-esophageal junction, but the Nkx2-5 expression pattern is otherwise 
unchanged (Figure 2.3Aiii). 
 
In a previous study, we found that Gata3 exhibits a pyloric-specific expression domain in the 
mesenchyme, similar to that of Nkx2-5[7]. To further characterize Gata3 expression at the 
pylorus, we examined dissected whole mount X-gal stained tissue from Gata3lacZ/+ embryos. 
Similar to Nkx2-5, Gata3 is expressed in a discrete band at the pylorus, as well as in the gastric 
ligaments (Figure 2.3Bi, black arrowheads). Notably, the pyloric Gata3 expression domain is  
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Figure 2.3 Gata3 and Nkx2-5 are expressed in similar domains at the pylorus. 
Whole mount X-gal staining of pylorus from (A) Nkx2-5lacZ/+ or (B) Gata3lacZ/+ mice at (i-ii) 
E14.5 and (iii) E18.5. (i,iii) Lateral view: stomach is left; duodenum is right; dorsal is top. (ii) 
Ventral view: stomach is top; duodenum is bottom. (Ai,Bi) Nkx2-5 and Gata3 have similar 
expression patterns, with extension dorsally into the pancreatic mesenchyme (PM in Aii) and 
ventrally into the gastric ligaments (black arrowheads in Ai and Bi), however, the width of the 
Gata3 expression domain is narrower than Nkx2-5. (Aii,Bii) Nkx2-5 expression is completely 
circumferential (red arrowhead in Aii), while Gata3 expression is discontinuous ventrally (red 
arrowhead in Bii). (Aiii,Biii) By E18.5, the gastric ligaments have lengthened to reach the 
esophagus (pancreatic mesenchyme outlined by dashed line in Aiii). Scale bars = 100 µm. 
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narrower than Nkx2-5, and on the lesser curvature (ventral) side, there is a small gap in the Gata3 
expression domain (Figure 2.3Bii, red arrowhead). 
 
Co-expression of pyloric transcription factors during pyloric sphincter maturation 
Self et al. previously showed that, between E12.5 and E14.5, Nkx2-5 and Sox9 are expressed in 
similar domains at the murine pylorus[16]. This is important since both of these genes have been 
implicated in pyloric development[8-11]. However, we were interested to: a) determine whether 
Nkx2-5 and Sox9 are co-expressed in the same cells; b) compare these domains with the 
expression pattern of Gata3; and, c) examine expression of these genes during establishment of 
the complete pyloric musculature (E14.5 to E16.5). 
 
The results of this expression analysis reveal distinct pyloric cell populations that are single, 
double, or triple positive for NKX2-5, SOX9, and/or GATA3, suggesting that a complex 
developmental circuitry directs pyloric development. At both E14.5 and E16.5, the expression 
domains of GATA3 and NKX2-5 are exclusively mesenchymal, while SOX9 is expressed in 
both epithelium and mesenchyme, as previously noted (Figure 2.5)[80]. A line of enteric neurons 
that are strongly positive for SOX9 and the neuronal marker peripherin, but negative for GATA3 
and NKX2-5 (Figure 2.4), separates the OLM and ICM domains (white lines in Figure 2.5). At 
E14.5, cells that are exclusively NKX2-5 positive are detected in the sub-epithelial mesenchyme 
and in the ICM (Figure 2.5Aviii, yellow arrowheads), while cells that express only GATA3 are 
located in the outermost dorsal pylorus, where it mixes with pancreatic mesenchyme (Figure 
2.5Aix, white arrowheads). Some of these GATA3 positive cells are epithelial in nature and may 
be part of the developing serosa (Figure 2.6). 
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Figure 2.4 Enteric neurons express SOX9 but not NKX2-5 or GATA3. 
Immunofluorescence of WT pylorus at E16.5: (i) DAPI; (ii) peripherin; (Aiii) NKX2-5; (Biii) 
GATA3; (Ciii) SOX9; or (iv) merged. (A-C) Enteric neurons express SOX9 (arrowheads in Civ) 
but not NKX2-5 or GATA3. Stomach is left; duodenum is right; and, dorsal is top. A dotted line 
is placed just beneath the line of peripherin positive neurons that separate ICM from OLM. 
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Figure 2.5 NKX2-5, GATA3, and SOX9 are co-expressed in dorsal pyloric OLM. 
Immunofluorescence of WT pylorus at (A) E14.5 or (B) E16.5 : (i,iv) DAPI; (ii,vii) SOX9; 
(iii,viii) NKX2-5; (iv,ix) GATA3; or (v,x) merged. (A-B) NKX2-5 single positive cells are found 
in the sub-epithelial mesenchyme and ICM (yellow arrowheads in Aviii), while GATA3 single 
positive cells are present in the pancreatic mesenchyme (white arrowheads in Aix). NKX2-5, 
GATA3, and SOX9 are co-expressed in the dorsal OLM (asterisks in Av,x and Bv,x). Stomach is 
left; duodenum is right; and, dorsal is top. Green lines mark the epithelial basement membrane, 
and white lines separate ICM and OLM. SM = sub-epithelial mesenchyme. Scale bars = 100 µm.
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Figure 2.6 GATA3 positive cells contribute to the serosal lining at the pylorus. 
GATA3 immunofluorescence of WT pylorus at E16.5: (i-ii) merged DAPI (blue) and GATA3 
(red) images; the dorsal pylorus within the boxed region in (i) is enlarged in (ii). GATA3 is 
expressed in the dorsal OLM and scattered epithelial cells in the serosal layer (white arrowheads 
in ii). Stomach is left; duodenum is right; and, dorsal is top. Green lines mark the epithelial 
basement membrane, and white lines separate ICM and OLM. 
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Cells that are triple positive for NKX2-5, GATA3, and SOX9 are visible at E14.5 as a loose 
cluster of cells located primarily within the nascent OLM territory on the dorsal side (Figure  
2.5Av,x, asterisk). Comparison with Figure 2.2 indicates that some of these cells are weakly 
αSMA positive (Figure 2.2Bvi, asterisk). Two days later, these OLM cells continue to express all 
three transcription factors (Figure 2.5Bv,x, asterisk) and now also strongly express 
αSMA (Figure 1Dvi, asterisk). Thus, cells that co-express all three transcription factors appear to 
contribute primarily to the OLM. 
 
Nkx2-5 is required for development and maintenance of the pyloric OLM 
The expression pattern of Nkx2-5 suggests a potential role for this transcription factor in pyloric 
development. However, germline deficiency of Nkx2-5 results in embryonic lethality by E10[7], 
precluding analysis of Nkx2-5 function in late embryogenesis. Thus, we paired a conditional 
Nkx2-5 allele (Nkx2-5flox/flox) with a tamoxifen-inducible Cre recombinase transgene driven 
from a ubiquitously expressed transgenic promoter (CAGGCre-ERTM)[19]. Two cohorts of 
pregnant dams were treated with once-daily tamoxifen injections, beginning at E14.5 or E16.5; 
each cohort was sacrificed two days later for analysis. 
 
Deletion of Nkx2-5 beginning at E14.5 leads to nearly complete absence of the αSMA positive 
pyloric OLM smooth muscle at E16.5 (Figure 2.7Av,vi, asterisks), suggesting that Nkx2-5 is 
necessary for the maturation of the OLM. Interestingly, Nkx-5 deletion beginning at E16.5, when 
the OLM is already formed and strongly expresses αSMA (Figure 2.2Dv,vi), significantly 
reduces OLM smooth muscle by E18.5 (Figure 2.7Bv,vi, asterisks). Remaining cells are loosely 
organized and weakly rather than strongly αSMA positive, suggesting that Nkx2-5 function is  
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Figure 2.7 Nkx2-5 is required for the development and maintenance of the dorsal pyloric OLM. 
Immunofluorescence of (i-iii) Nkx2-5flox/flox (WT) or (iv-vi) CAGGCre-ERTM;Nkx2-
5flox/flox (N25 CKO) pylorus (after two days of intraperitoneal tamoxifen injections) harvested 
at (A) E16.5 or (B) E18.5: (i,iv) DAPI;  (ii,v) αSMA; or (iii,vi) merged. (A) In N25 CKO mice at 
E16.5, cell mass and αSMAexpression is reduced in the dorsal OLM (asterisks). (B) At E18.5, 
the dorsal OLM in WT mice has expanded further and shows increased αSMA expression (Bi-
iii). Deletion of Nkx2-5 beginning at E16.5, when the dorsal OLM is already αSMApositive 
(Aii-iii), leads to its regression. Stomach is left; duodenum is right; and, dorsal is top. Green 
lines mark the epithelial basement membrane, and white lines separate ICM and OLM. Asterisk 
= dorsal pyloric OLM. Scale bars = 100 µm. 
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continuously required for the maintenance of differentiated smooth muscle cells within this 
fascicle. 
 
Increased apoptosis and reduced proliferation in pyloric OLM after loss of Nkx2-5 
Our data show that loss of Nkx2-5 beginning at E14.5 prevents the maturation of the pyloric 
OLM fascicle, and deletion of this gene after the fascicle has formed at E16.5 leads to its  
regression. Reduced smooth muscle cell proliferation and/or increased apoptosis are potential 
mechanisms underlying these OLM responses. To examine proliferative changes, timed-pregnant 
dams were injected with BrdU two hours prior to sacrifice. In wild type (WT) animals, BrdU 
positive cells were found scattered throughout the ICM and OLM regions at E14.5 and E16.5 
(Figure 2.8A). Conditional deletion of Nkx2-5 beginning at E14.5 was associated with a 25% 
reduction in the proportion of proliferative cells in the OLM fascicle at E16.5 (19.6% in WT 
versus 14.8% after Nkx2-5 deletion, P < 0.05) (Figure 2.8B, Ci). Though Nkx2-5 is also 
expressed in the ICM, no significant change in proliferative activity was detectable in that 
domain (Figure 2.8Cii). 
 
To assess the impact on apoptosis, we examined Caspase3 (Casp3) expression 24 and 48 hours 
after deletion of Nkx2-5. At 48 hours post-deletion, the OLM fascicle was largely absent, and the 
remaining cells were not Casp3 positive (data not shown). At 24 hours post-deletion, though the 
total number of cells (as well as the number of Nkx2-5 positive cells) had already decreased, the 
proportion of Casp3 positive cells within the OLM had nearly doubled (2.6% in WT versus 4.8% 
after Nkx2-5 deletion, P = 0.07) (Figure 2.9). We conclude that deletion of Nkx2-5 results in 
decreased proliferation, increased apoptotic activity and rapid loss of the dorsal pyloric OLM  
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Figure 2.8 Decreased cellular proliferation in the pyloric OLM after Nkx2-5 deletion. 
Immunofluorescence of (A) WT or (B) N25 CKO pylorus at (Ai-ii) E14.5 or (Aiv-vi,Bi-iii) 
E16.5: (i,iv) DAPI; (ii,v) BrdU; or, (iii,vi) merged. (A) Proliferative cells are scattered 
throughout the WT ICM and OLM. (B) After Nkx2-5 deletion, the dorsal OLM (red dashed line 
in Avi,Biii) is smaller but still contains proliferative cells. (C) Quantitation of BrdU positive 
cells, as a percentage of total (i) OLM or (ii) ICM cell mass, demonstrates decreased 
proliferation in the OLM but not ICM after Nkx2-5 deletion. Stomach is left; duodenum is right; 
and, dorsal is top. Green lines mark the epithelial basement membrane, and white lines separate 
ICM and OLM. Scale bars represent 100 µm. Error bars represent standard error of the mean. 
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Figure 2.9 Increased cellular apoptosis in the pyloric OLM after Nkx2-5 deletion. 
(A) Immunofluorescence of (i-iv) WT or (v-viii) N25 CKO pylorus (after 24 hours of 
intraperitoneal tamoxifen injections) at E16.5: (i,v) DAPI; (ii,vi) NKX2-5; (iii,vii) Casp3; or, 
(iv,viii) merged. (A) After Nkx2-5 deletion, the OLM is smaller (red dashed outline in iii,vii), 
and there are fewer NKX2-5 positive cells (ii,vi) but more Casp3 positive cells (white 
arrowheads in iii,vii). (B) Quantitation of (i) total cells, (ii) total NKX2-5 positive cells, (iii) total 
Casp3 positive cells, (iv) percent of NKX2-5 positive cells, and (v) percent Casp3 positive cells 
in the dorsal pyloric OLM of WT (white) or N25 CKO (gray) mice. After Nkx2-5 deletion, there 
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fascicle. Interestingly, though the ICM also expresses Nkx2-5, proliferation and apoptosis within 
this domain does not appear to be altered, indicating that a distinct molecular network directs the 
maturation of this muscle cell population. 
 
Gata3 is necessary for the formation of the pyloric OLM fascicle 
 
Since cells of the dorsal pyloric OLM express both Gata3 and Nkx2-5 (Figure 2.5), we next 
examined the consequences of germline Gata3 loss on the development of this fascicle. Though 
germline Gata3 deficiency results in early embryonic lethality, Gata3 null embryos can be 
pharmacologically rescued by catecholamine administration in utero and will survive until birth, 
permitting the analysis of Gata3 function in later fetal development[110, 113].  We found no 
obvious pyloric abnormalities in Gata3 null animals at E14.5 (data not shown). However, by 
E16.5, Gata3 deficiency results in nearly complete absence of the OLM fascicle (Figure 
2.10Aiv-vi, asterisks), a phenotype highly similar to that seen after Nkx2-5 conditional deletion. 
 
Loss of Gata3 or Nkx2-5 alters ICM morphogenesis and pyloric sphincter constriction 
As shown in Figures 4A and 5A, conditional Nkx2-5 deletion or germline Gata3 deficiency leads 
to loss of the dorsal OLM fascicle. In both cases, at E16.5, the shape of the dorsal ICM is clearly 
altered, as depicted in the tracings shown in Figure 2.10B. Since Gata3 is not widely expressed 
in the ICM (Figure 2.5), the shape change detected in this mutant model must be secondary to 
the loss of the OLM. In addition, at E18.5, the pyloric sphincter constriction is attenuated in both 
genetic deficiency models; compared to wild type (95% CI = 231-266 µm), the constriction is  
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Figure 2.10 Gata3 is required for formation of the dorsal pyloric OLM; absence of Gata3 or loss 
of Nkx2-5 alters ICM shape and pyloric sphincter constriction. 
(A) Immunofluorescence of (i-iii) WT or (iv-vi) Gata3lacZ/lacZ (Gata3 KO) pylorus at E16.5: 
(i,iv) DAPI;  (ii,v) αSMA; or (iii,vi) merged. Germline deficiency of Gata3 results in nearly 
complete absence of αSMA positive cells in the dorsal pyloric OLM. (B) Tracings of the pyloric 
ICM (red) and OLM (white area defined by the dotted line) in WT, N25 CKO, and Gata3 KO 
mice at E16.5. Subtle but reproducible changes occur in the shape of the ICM in N25 CKO and 
Gata3 KO mice. (C) αSMA immunofluorescence of (i) WT, (ii) N25 CKO, or (iii) Gata3 KO 
pylorus at E18.5. Compared to WT, the pyloric sphincter constriction is somewhat reduced 
(wider) in N25 CKO animals and significantly attenuated in Gata3 KO (sphincter constriction 
measurements are shown in Civ). Stomach is left; duodenum is right; and, dorsal is top. Green 
lines mark the epithelial basement membrane, and white lines separate ICM and OLM. Red lines 
in (Ci-iii) denote width of pyloric sphincter constriction. Asterisk = dorsal pyloric OLM. Scale 
bars = 100 µm. Error bars represent one standard deviation from the mean. 
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Figure 2.11 Regulatory hierarchy among Nkx2-5, Gata3 and Sox9 in the dorsal pyloric OLM. 
Immunofluorescence of (A) WT, (B) N25 CKO, or (C) Gata3 KO pylorus at E16.5: (i) DAPI; 
(ii) SOX9; (iii) NKX2-5; (iv) GATA3; or (v) merged. (A-C) Conditional loss of Nkx2-5 
effectively eliminates dorsal OLM NKX2-5 expression, with concomitant loss of SOX9 
expression, but does not abrogate GATA3 expression. Germline deficiency of Gata3 is 
associated with the complete absence of dorsal OLM SOX9 expression, but NKX2-5 is 
expressed in rare remaining dorsal OLM cells. Stomach is left; duodenum is right; and, dorsal is 
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40% wider in Gata3 null animals (95% CI = 267-450 µm, P < 0.05) and 22% wider after 
conditional Nkx2-5 deletion (95% CI = 228-379 µm, P = 0.13) (Figure 2.10C). 
 
A regulatory hierarchy of pyloric transcription factors 
We next examined the expression of NKX2-5, GATA3 and SOX9 in E16.5 pyloric smooth 
muscle after conditional Nkx2-5 deletion or in Gata3 null mice. Deletion of Nkx2-5 starting at 
E14.5 effectively ablates NKX2-5 expression in the majority of cells at the E16.5 pylorus (Figure 
2.11Biii). While SOX9 staining is absent in smooth muscle cells (Figure 2.11Bii), GATA3 
expression persists in NKX2-5 negative cells of the OLM remnant (Figure 2.11Biv), suggesting 
that Nkx2-5 is required for Sox9 but not Gata3 expression in this domain. 
 
In Gata3 null mice, GATA3 expression is absent (Figure 2.11Civ), as is SOX9 in smooth muscle 
cells (Figure 2.11Cii), but NKX2-5 expression is readily apparent in cells of the remaining OLM 
territory (Figure 2.11Ciii). Thus, Gata3 is required for Sox9 but not Nkx2-5 expression in the 
dorsal pyloric OLM. Taken together, these data reveal a pyloric transcriptional hierarchy in 
which Nkx2-5 and Gata3 are independently required to drive Sox9 expression and, consequently, 
smooth muscle development within the dorsal OLM fascicle. 
 
Loss of Nkx2-5 or Gata3 does not affect the epithelial pyloric border 
In the chick, perturbation of mesenchymal NKX2-5 activity changes the character of the pyloric 
epithelium, suggesting that signaling molecules driven by NKX2-5 are responsible for dictating 
epithelial phenotype[5, 78]. In the mouse, the distinct characters of the stomach and duodenal 
epithelia are established between E14.5 and E16.5[6, 7], a time coincident with the development 
of the OLM fascicle (Figure 2.2). Therefore, we assessed the integrity of the epithelial stomach- 
 70
  
Figure 2.12 The epithelial pyloric border is unaltered in the absence of Nkx2-5 or Gata3. 
CDX2 immunohistochemistry in (A) WT, (B) Gata3lacZ/lacZ (G3 KO), or (C) N25 CKO 
pylorus at E18.5. (A) CDX2 is expressed in intestinal but not antral epithelial cells (i.e., the 
epithelial pyloric border) in WT pylorus. (B-C) Despite concomitant pyloric muscular 
hypoplasia, this boundary of epithelial CDX2 expression is preserved in N25 CKO and G3 KO 
mice. 
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intestinal (pyloric) border at E18.5 after conditional Nkx2-5 deletion and in Gata3 null animals 
by examining the expression of CDX2, an intestine-specific epithelial marker. In both models, 
the position of the epithelial pyloric border was similar to wild type (Figure 2.12). Thus, in the 
mouse, neither Gata3 nor Nkx2-5 is required for positioning of the epithelial pyloric border. 
 
2.4 Discussion 
 
Here, we provide a detailed analysis of normal pyloric muscle development at the cellular level, 
revealing an unexpectedly complex expression pattern of three critical transcription factors in 
these muscles. We provide evidence for a redundant regulatory mechanism that controls the 
development of a specific dorsal OLM fascicle at the pylorus. This fascicle is first detectable as a 
population of loosely organized, weakly αSMA positive smooth  muscle cells at E14.5; it 
organizes considerably over the next two days, becoming highly αSMA positive and displacing 
the ICM to generate a distinct pyloric sphincter constriction by E16.5. Cells within this dorsal 
OLM fascicle express NKX2-5, GATA3, and SOX9. Deletion of either Nkx2-5 or Gata3 
abrogates development of this OLM fascicle, results in loss of SOX9 expression, and alters 
pyloric muscular shape. While both Nkx2-5 and Gata3 are also expressed in other cells at the 
pylorus, loss of either factor appears to affect only the phenotype of triple positive cells (NKX2-
5, GATA3, and SOX9) within the dorsal OLM fascicle. 
 
This is the first study to characterize Gata3 pyloric expression at the cellular level and to 
establish a role for Gata3 in pyloric development. We find that GATA3 is expressed in cells on 
the serosal surface (Figure 2.6) and in cells that intermix with pancreatic mesenchyme (Figure 
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2.5); neither of these cell types co-expresses NKX2-5 or SOX9, and their functional role remains 
undetermined since no obvious phenotype was detected in serosa or pancreas in Gata3 deficient 
mice. In contrast, the effect of Gata3 loss on the pyloric OLM fascicle is dramatic and directly 
mirrors the effects of Nkx2-5 loss. Despite this similarity in phenotype, we found no clear 
evidence of a transcriptional relationship between Gata3 and Nkx2-5. Further supindependent 
regulation of these factors, conditional overexpression of Wnt9b or activation of a stabilized form 
of beta-catenin in the distal stomach and pylorus affects Nkx2-5 and Gata3 expression 
oppositely: the Nkx2-5 domain is expanded, while expression of Gata3 is abolished[109]. 
 
Interestingly, both Nkx2-5 and Gata3 are required for pyloric sphincter morphogenesis and both 
directly or indirectly regulate Sox9 expression. Three other transcription factors, Barx1, Bapx1, 
and Six2, are also important for pyloric sphincter development and pyloric Sox9 expression[80, 
105, 107, 108]. All three factors are expressed in distal stomach as well as pylorus. It has been 
proposed that Bapx1 functions downstream of Barx1, since its expression is lost in Barx1 mutant 
mice[105]. Interestingly, loss of Bapx1 does not affect Nkx2-5 expression, but gene expression 
microarrays demonstrate decreased Sox9 in Bapx1 null animals[105, 108]. Thus, Bapx1 may 
regulate Sox9 expression directly or indirectly via Gata3. Loss of Six2 also results in attenuation 
of the pyloric sphincter constriction and is associated with transient loss of Nkx2-5 and complete 
loss of SOX9 expression[80]. Thus, all of these models converge on Sox9 and given its 
expression in the OLM (Figure 2.5), it will be important to directly determine whether Sox9 is 
required for development of this OLM fascicle and establishment of pyloric sphincter 
constriction. Testing this possibility will require a transgenic Cre driver that is active in the 
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pyloric mesenchyme but not the epithelium, where Sox9 plays a critical role in establishing the 
stem cell zone[126, 127]. 
 
Both Nkx2-5 and Gata3 are important for proper differentiation of the OLM fascicle, since in 
their absence, cells are disorganized and only weakly αSMA positive. Even very late deletion of 
Nkx2-5 (after the OLM has fully developed) results in an OLM fascicle that is reduced in size, 
organization, and differentiation. Co-regulation of muscle differentiation genes by NKX and 
GATA family members has been seen in other systems: NKX3-2 and GATA6 cooperatively 
activate smooth muscle genes (e.g., Itga1, SM22α, and Cald1), while NKX2-5 and GATA4 co-
activate cardiac muscle genes (e.g., Anf)[128]. In both cases, co-regulation also involves serum 
response factor (SRF), an important regulator of muscle gene expression in differentiating 
cardiac and smooth muscle. These three proteins together (SRF/GATA/NKX) synergistically 
activate target gene expression at levels 5-10 fold greater than SRF/GATA or SRF/NKX 
alone[128].  Thus, it is possible that loss of either Nkx2-5 or Gata3 disrupts ternary complexes of 
GATA3, NKX2-5, and SRF that are required for the expression of genes involved in the 
differentiation and/or maintenance of pyloric smooth muscle. This remains to be directly tested. 
 
Failure to establish or maintain the proper pyloric musculature, as seen in both the conditional 
Nkx2-5 deletion and Gata3 null models examined here, could potentially underlie some cases of 
primary duodenogastric reflux, a rare and poorly understood condition involving excessive reflux 
of bile acids from the duodenum to the stomach[19]. IHPS, in contrast, presents as pyloric 
obstruction as opposed to lack of constriction. Given that recent GWAS data link nucleotide 
polymorphisms near the NKX2-5 gene locus to IHPS[13], our results would predict that some 
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forms of IHPS may result from overexpression of NKX2-5 at the pylorus. For example, a change 
in an intergenic regulatory element could readily account for increased pyloric NKX2-5 
expression. Indeed, an upstream enhancer that drives pyloric Nkx2-5 expression in mice has 
already been described[124] and it will be interesting to examine the sequence of this region in 
patients with IHPS. Additionally, our data suggest that the search for linked polymorphisms in 
IHPS should be expanded to include GATA3 and, potentially, SOX9. 
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Table 1. Gata3 KO pyloric constriction data. 
 WT (μm) N25 CKO (μm) Gata3 KO (μm) 
Length #1 234.8 347.7 453.0 
Length #2 244.2 226.3 319.1 
Length #3 269.9 338.1 305.6 
Length #4 210.6 - - 
Average 249.7 304.0 359.2 
Standard 
deviation 18.1 67.5 81.5 
P = 0.036 (Gata3 KO vs. WT)  
P = 0.132 (N25 CKO vs. WT) 
 
Table 2. N25 CKO BrdU quantitation data.  
 
WT OLM N25 CKO OLM 
DAPI (#) BrdU (#) BrdU (%) DAPI (#) BrdU (#) BrdU (%) 
Count #1 180 38 21.1 96 18 18.8 
Count #2 208 33 15.9 85 12 14.1 
Count #3 170 37 21.8 84 13 15.5 
Count #4 125 24 19.2 100 12 12.0 
Count #5 146 29 19.9 104 11 10.6 
Count #6 - - - 89 16 18.0 
Average   19.6   14.8 
Standard 
deviation   2.3   3.2 
P = 0.023 (N25 CKO vs. WT) 
 
 
WT ICM N25 CKO ICM 
DAPI (#) BrdU (#) BrdU (%) DAPI (#) BrdU (#) BrdU (%) 
Count #1 97 21 21.6 98 12 12.2 
Count #2 79 17 21.5 90 17 18.9 
Count #3 86 19 22.1 80 17 21.3 
Count #4 86 18 20.9 124 25 20.2 
Count #5 85 19 22.4 88 14 15.9 
Count #6 - - - 64 16 25.0 
Average   21.7   18.9 
Standard 
deviation   0.6   4.4 
P = 0.196 (N25 CKO vs. WT) 
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Table 3. N25 CKO Casp3 quantitation data.  
 
 Casp3 (#) Nkx2-5 (#) Total cells (#) Casp3 (%) Nkx2-5 (%)
WT count #1 3 104 293 1.0 35.5 
WT count #2 8 184 335 2.4 54.9 
WT count #3 6 111 305 2.0 36.4 
WT count #4 16 216 311 5.1 69.5 
WT count #5 8 145 321 2.5 45.2 
Mut count #1 5 36 153 3.3 23.5 
Mut count #2 10 34 145 6.9 23.4 
Mut count #3 6 31 132 4.5 23.5 
Mut count #4 7 33 152 4.6 21.7 
WT average 8.2 152 313 2.6 48.3 
WT SEM 2.4 23.9 8.0 0.8 7.1 
Mut average 7 33.5 145.5 4.8 23.0 
Mut SEM 1.1 1.0 4.8 0.8 0.4 
P < 0.001 (total cells #; N25 CKO vs. WT) 
P = 0.002 (Nkx2-5 #; N25 CKO vs. WT) 
P = 0.661 (Casp3 #; N25 CKO vs. WT) 
P = 0.010 (Nkx2-5 %; N25 CKO vs. WT) 
P = 0.066 (Casp3 %; N25 CKO vs. WT) 
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Chapter 3 2 
Development of the Pyloric Ligaments 
Summary 
A number of ligament structures connect the stomach and intestine with surrounding organs, 
most of which consist primarily of vascular and nervous tissue that provides perfusion and nerve 
connectivity between the connected organs.  On the lesser curvature side of the stomach, a pair 
of superficial cord-like structures, referred to previously as gastric ligaments, extends from the 
pyloric constriction to the gastroesophageal junction. Though these structures have been 
recognized in many mammalian species, very little is known about their cellular composition, 
function or development. We examined cellular structure and gene expression (of αSMA, 
peripherin, CD31) in these organs at E12.5, E14.5, E16.5, P0 and P30.  We show that the gastric 
ligaments originate at E12.5 as αSMA positive outgrowths from the pyloric outer longitudinal 
muscle (OLM) and extend to the esophagus around birth. These ligaments are composed of 
smooth muscle and covered by serosa. Throughout their development, the gastric ligaments 
express the transcription factors Gata3 and Nkx2-5. Since both of these factors are also expressed 
in the pyloric OLM and necessary for its proper development (Udager et al. unpublished data), 
we examined the pyloric gastric ligaments for expression of these transcription factors and 
assessed ligament integrity in mouse models that lack each gene. As the ligaments form, the 
expression domain of both factors expands along the growing ligament structures. Germline loss 
                                                 
2 This chapter is being prepared for submission to Developmental Dynamics. It includes contributions from Aaron 
Udager, David Saenz, and Deborah Gumucio 
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of Gata3 impairs development of the gastric ligaments. Conditional loss of Nkx2-5, at a time 
after ligaments have formed, results in reduced αSMA expression and hence reduced 
differentiation of their smooth muscle component. In light of their direct structural and molecular 
connection to the pyloric OLM, we propose to rename these structures as: pyloric ligaments. We 
speculate that they may act, together with the OLM, to flex or stabilize the pyloric region, 
actions that may promote proper pyloric sphincter function. 
 
3.1 Introduction 
The connective tissue ligaments of the gastrointestinal tract perform a critical role in supporting 
gastrointestinal motility and perfusion.  These ligaments are named for their points of origin and 
insertion and include the gastrosplenic, gastrophrenic, gastrocolic, hepatogastric, 
hepatoduodenal, and splenorenal ligaments, the suspensory ligament of the duodenum (ligament 
of Treitz) and the gastric ligaments. Of these, the ligament of Treitz and the gastric ligaments are 
the only ones that do not consist primarily of neurovascular tissue and have been speculated to be 
similar in function [125]. 
 
The ligament of Treitz is thought to provide structural support within the gastrointestinal tract. 
Morphologically, it is sometimes described as consisting of two distinct subunits [129]. The 
upper part, also called the Hilfsmuskel, is a skeletal muscle structure that extends from the 
diaphragmatic crus to the celiac axis; the lower part, known as the suspensory muscle of the 
duodenum, is composed of smooth muscle and extends from the duodenum upward to the celiac 
axis [129, 130]. However, these two segments are compositionally different and appear to have 
distinct origins, with the Hilfsmuskel originating from the diaphragm [131] and the suspensory 
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muscle of the duodenum originating form the outer longitudinal smooth muscle of the duodenum 
[131, 132]. Therefore, it has been argued that these two structures are distinct entities [130, 133]. 
Functionally, the ligament of Treitz/suspensory muscle of the duodenum is thought to maintain 
the flexure of the duodenojejunal junction and facilitate the embryologic rotation of the bowel 
[130, 134].  
 
The gastric ligaments consist of a pair of bilateral, superficial cord-like structures, located on the 
lesser curvature of the stomach, that extend from the pylorus to the connective tissue surrounding 
the esophagus [125]. The development and composition of these ligaments have not been 
carefully examined, but they have been speculated to control the angle of flexure between the 
duodenum and antrum [125]. Recently, while characterizing gene expression pattern in the inner 
circular (ICM) and outer smooth longitudinal (OLM) smooth muscle layers of the pyloric 
sphincter (Udager et. al. manuscript submitted), we discovered that expression domains for the 
transcription factors Nkx2-5 and Gata3 appeared to be physically contiguous between the gastric 
ligaments and the pyloric OLM (Udager et al. Manuscript submitted).  After germline deletion of 
Gata3 or conditional ablation of Nkx2-5 from developing embryos, the pyloric OLM is sharply 
attenuated and the remaining cells are only weakly αSMA positive. Thus, both Gata3 and Nkx2-
5 are required for proper development of the pyloric OLM. However the fate of the gastric 
ligaments was not assessed in that study.  
 
Here, we examine the development of the gastric ligaments between E12.5 and P30. We 
demonstrate that these structures contain minimal neurovascular tissue, but are composed 
primarily of smooth muscle and lined by serosa. As was the case for the OLM, both Gata3 and 
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Nkx2-5 are required for proper maturation of the gastric ligaments. Also similar to the pyloric 
OLM, Sox9 is expressed in the gastric ligaments and loss of either Gata3 or Nkx2-5 results in 
loss of Sox9 expression. These molecular similarities between the gastric ligaments and the 
OLM, combined with the physical contiguity of the OLM and ligament structures, suggests that 
they may work together to control the flexure of the pyloric region. On this basis, we suggest that 
these structures should be called “pyloric ligaments”. 
 
3.2 Results 
Normal development of the pyloric ligaments 
We examined the ventral side (lesser curvature) of the pyloric region between E14.5 and E16.5 
in wild-type mice in order to assess the origin of the pyloric ligaments and characterize their 
development. The pyloric ligaments appear as outgrowths of the pyloric OLM at E14.5 (Figure 
3.1). At this time, the ligaments extend anteriorly along the lesser curvature of the stomach and 
do not thin significantly from their base to their tip. By E16.5, the ligaments extend further up 
the lesser curvature of the stomach. They appear thinner at this point and terminate in connective 
tissue around the base of the esophagus. By E16.5, the cells of the ligament core are elongated in 
the anterior/posterior direction and the lining cells have further flattened (Figure 3.1).   
 
Tissue characterization of the developing pyloric ligaments 
To characterize the cell populations present within the pyloric ligaments, we stained sectioned 
tissue for αSMA, peripherin, and CD31 for muscle, nervous, and vascular tissue respectively. At 
early timepoints, while the ligament is a short outgrowth of the pyloric tissue (Figure 3.2A), none  
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Figure 3.1 Development of the pyloric ligament 
H&E stained sectioned tissue of E14.5 (A-B) and E16.5 (C-D) pyloric tissue. (A) The early 
pyloric ligament (indicated by the dotted black line) is an outgrowth of the ventral side of the 
pylorus. (B) The ligament is lined by a unique layer of narrow, elongated cells (asterisks), and  
anchored to the esophagus and ventral stomach by loose connective tissue (arrowheads). (C) By 
E16.5, the ligament thins and elongates, while maintaining its overall architecture.  
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of these markers is expressed at significant levels  (Figure 3.2A-D). Over the next two days, 
αSMA expression within these cells strengthens (Figure 3.2G, H,K,L) considerably. In contrast,  
periferin staining reveals no obvious nervous tissue within the gastric ligament at E14.5 (Figure 
20B) and limited nervous tissue at E16.5 (Figure 3.2 J).  Robust peripherin expression is detected 
in the cells of the myenteric plexuses within the antral wall at both E14.5 (Figure 3.2B) and 
E16.5 (Figure 3.2J). Similarly, limited vascular endothelial tissue is present within the pyloric 
ligaments (Figure 3.2F). Thus, the pyloric ligaments are primarily muscular structures. 
 
Expression of pyloric transcription factors in the pyloric ligaments 
Our earlier studies of Nkx2-5, Gata3 and Sox9 revealed that all three of these factors are co-
expressed in a fascicle of OLM at the pylorus (Udager et al., manuscript submitted; see Chapter 
2). Additionally, whole mount analyses suggested that Nkx2-5 and Gata3 were expressed in the 
pyloric ligaments and that this expression domain extended directly from the pyloric OLM. 
However, the expression of these factors was not examined in the pyloric ligaments on a cellular 
basis in that study. Here, we show that in E14.5 sectioned tissue, expression of both Gata3 and 
Nkx2-5 is detectable in the central rounded cells of the ligaments (Figure 3.3). Additionally, the 
flattened serosal cells surrounding the ligaments are GATA3 positive but NKX2-5 negative, 
similar to some of the serosal cells seen on the outer edges of the OLM (Udager et al., 
Manuscript submitted; Chapter 2). SOX9 expression is also present within the pyloric ligament 
muscle (Figure 3.3). These expression profiles remain unchanged at E16.5 (data not shown). 
 
Loss of Gata3 or Nkx2-5 affects development of the pyloric ligaments 
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Figure 3.2 The pyloric ligaments are muscular structures  
Frozen (E-H) or paraffin (A-D, I-L) sectioned tissue of E14.5 (A-D) and E16.5 (E-L) wild-type 
tissue shows the expression of muscular and neurovascular structures in and around the pyloric 
ligments. (A-D) At E14.5, there is limited αSMA expression within the developing pyloric cords 
(white arrowheads), and peripherin expression is largely limited to the enteric plexes associated 
with the ICM. (E-H) Limited vascular tissue is visible at E16.5, but the intensity of SMA 
staining has increased. (I-L) There is limited expression of peripherin within the cells of the 
pyloric cord but robust αSMA staining is detectable. 
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Figure 3.3 Pyloric transcription factors are expressed in the pyloric ligaments 
Paraffin sectioned tissue from an E14.5 wild-type mouse pylorus. (A) Sox9 is expressed within 
the core of the pyloric ligament at E14.5. (B) Nkx2-5 expression is strong throughout the 
ligaments, with expression extending from the ligament onto the ventral aspect of the pylorus. 
(C) Gata3 is expressed throughout the ligament, but less robustly in the ventral pylorus. (D) An 
overlay of Sox9 (blue), Nkx2-5 (red), and Gata3 (green) expression in the pyloric ligament 
reveals a subset of cells in the core of the ligament in which all three transcription factors are 
coexpressed. 
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We previously demonstrated that, in the absence of either Gata3 or Nkx2-5, differentiation of 
pyloric muscular tissue is reduced. Furthermore, we showed the loss of one of these factors did 
not affect the expression of the other (Udager et al., Manuscript submitted; Chapter 2).  Thus, we  
examined the consequences of loss of Gata3 or Nkx2-5 on the pyloric ligaments. In Gata3lacZ/lacZ 
knockout mice, the pyloric ligaments are severely reduced in size (Figure 3.4). The attenuated 
ligaments contain cells that are only weakly αSMA positive. The Gata3 deficient vestigial 
ligaments still express NKX2-5, suggesting that, as in the OLM, Gata3 is not required for the 
maintenance of Nkx2-5 expression in these structures (Figure 3.4A-D).  
 
Because germline Nkx2-5 deletion is lethal in the early embryo due to its role in heart 
development, we utilized a conditional deletion model to examine the role of this factor in 
pyloric ligament development. Nkx2-5f/f mice were mated to CAGG-Cre-ER mice, tamoxifen 
was given at E14.5 and E15.5 and tissues were harvested at E16.5.  The pyloric ligaments (which 
had fully formed by this time) were similar to wild type in size and shape. However, the central 
cells did not express αSMA, suggesting that muscular maturation is inhibited (Figure 3.4E-H). 
While no NKX2-5 staining was visible in the ligament (confirming the knockout), GATA3 was 
expressed (Figure 3.4G). Thus, no epistatic relationship can be demonstrated between Gata3 and 
Nkx2-5 in the OLM (Udager et al., Manuscript submitted; Chapter 2) or in the pyloric ligaments. 
 
Three dimensional reconstruction reveals continuity between the pyloric ligaments and the 
pyloric OLM 
In earlier studies (Udager et al., Manuscript submitted; Chapter 2), we noted that the expression 
of Nkx2-5 and Gata3 at the pylorus appears to be continuous with expression in the gastric  
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Figure 3.4 Loss of Nkx2-5 or Gata3 leads to decreased smooth muscle expression 
Sectioned tissue from E16.5 Gata3lacZ/lacZ (G3KO) or Nkx2-5f/f;Cagg-CreERT2 (N25CKO) 
mice. (A) Germline loss of Gata3 does not abrogate Nkx2-5 expression in the developing pyloric 
cord. (B) The cord itself is thinner and expresses less αSMA than wild-type. (C) Gata3 
expression is absent, confirming the knockout. (D) An overlay of Nkx2-5(blue), αSMA (red), 
and Gata3 (Green) shows that Gata3 expression is absent while Nkx2-5 expression is still robust 
within the cord. (E) In Nkx2-5 deletion mice Nkx2-5 expression is undetectable. (F) While the 
cord thickness is similar to wild type, there is a significant decrease in αSMA expression within 
it. (G) Gata3 expression is still robust in the pyloric cord after the deletion of Nkx2-5. (H) An 
overlay of all three genes. 
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ligaments. We also noted a subtle difference in the expression patterns of these two factors, in 
that expression of NKX2-5 appeared to be fully circumferential while that of GATA3 exhibited a 
gap on the ventral side of the pylorus, between the two pyloric ligaments. To better understand  
the relationship between the pyloric OLM and the ligaments, we used serial cross-sections and 
Imaris software to rebuild a portion of the pylorus in three dimensions. Sections were stained for 
αSMA and GATA3 and the continuity of staining was assessed in both individual sections and in 
the rebuilt three-dimensional image. As shown in Figure 3.5, we found that the muscle of the 
pyloric OLM is indeed continuous with that of the pyloric ligaments. Additionally, continuity of 
expression of GATA3 is demonstrable. Moreover, on the ventral side of the pylorus, αSMA 
staining reveals that the OLM layer (which expresses both Nkx2-5 and Gata3, see Chapter 2) is 
extremely thin or missing altogether, while the ICM layer (which expresses Nkx2-5, but not 
Gata3, see Chapter 2) is fully circumferential. These reconstructions provide an explanation for 
the apparent gap in Gata3 expression on the ventral side of the pylorus seen in whole mount 
sections. 
 
3.3 Discussion 
This analysis of the development of the pyloric ligaments reveals that these ligaments extend 
from their pyloric origin at E14.5, with expression extending to the esophagus by E16.5.  Three 
dimensional reconstructions reveal clear continuity between the pyloric ligaments and the outer 
longitudinal muscle of the pylorus. Additionally, these reconstructions confirm the lack of OLM 
on the ventral side of the stomach in the region between the pyloric ligaments, noted earlier 
(Udager et al., manuscript submitted). Thus, the structure of this muscular fascicle resembles a 
saddle, with the stirrups angled anteriorly toward the esophagus (Figure 3.5). Interestingly, the  
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Figure 3.5 The pyloric ligaments are continuous with the pyloric OLM 
3D reconstruction of αSMA (red) and Gata3 (green) expression shows the  pyloric ligaments are 
continuous with the pyloric OLM (white arrows), and are distinct from the ICM (star). (A) An 
anterior image of the pyloric ligaments show the ligaments descending from the ventral antrum 
to the level of the pylorus and joining with the pyloric OLM (white arrows). (B) This structure is 
better revealed with a lateral view. (C) In sections, it becomes obvious that Gata3 expression is 
limited to the ligaments and the pyloric OLM (white arrows) and not the pyloric ICM. 
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lack of outer longitudinal muscle at the inner curvature of the pylorus is a feature that is shared 
by the pig stomach [1] several other species also show thin OLM in this region [1].The similarity 
between the pyloric ligaments and the OLM extends to the characteristic molecular expression  
domains that characterize these structures, as well as to the requirement for Nkx2-5 and Gata3. 
The pyloric ligaments express Nkx2-5, Gata3 and Sox9, as does the OLM (Udager et al, 
manuscript submitted). The ICM expresses Nkx2-5, but not the other two factors. In the absence 
of Gata3, or after the conditional deletion of Nkx2-5, the pyloric ligaments become attenuated 
and αSMA expression is reduced. A similar phenotype was seen in the OLM (Udager et al, 
manuscript submitted). Also as seen in the OLM, no dependent regulatory relationship can be 
discerned between Gata3 and Nkx2-5 (Udager et al, manuscript submitted).  
 
These data represent the first molecular and cellular characterization of the pyloric ligaments. As 
muscular structures, the pyloric ligaments differ from other ligaments of the stomach, which are 
critical in providing neurovascular connections between the tissues [134]. Based on their position 
and contiguity with the OLM, connecting the ventral pylorus to the distal esophagus, it is 
possible that these ligaments are necessary for determining the angle between the stomach and 
duodenum, in a manner similar to the proposed function of the ligament of Treitz. Indeed, a role 
for these ligaments in flexure was suggested by Torgersen, based on anatomical and radiological 
analysis of pyloric regions from multiple species, including dog, pig, cat, horse and human [125]. 
It will be of great interest to further probe the contribution of the pyloric ligaments to pyloric 
function and to analyze their character in the context of idiopathic hypertrophic pyloric stenosis.  
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Chapter 4  
Conclusion 
Summary  
The work presented in the previous chapters expands our current understanding of pyloric 
development by identifying the function of Nkx2-5 and Gata3 at the pylorus, and relating both 
genes to the existing pyloric signaling network at the pylorus. We showed that both Gata3 and 
Nkx2-5 are involved in pyloric muscular development (see Chapter 2). Specifically, both Nkx2-5 
and Gata3 are necessary for the formation of the pyloric OLM, the absence of which causes 
significant changes to pyloric morphology and a loss of pyloric constriction (Figure 2.10). In 
addition, we investigated the mechanism by which loss of Nkx2-5 affects pyloric muscular 
development, showing that changes to both proliferation and apoptosis contribute to the loss of 
the pyloric OLM. Unlike the avian model, loss of Nkx2-5 did not affect the character of the 
pyloric epithelium, suggesting that its function at the mammalian pylorus is distinct from that in 
the avian pylorus. Our data also extend the current understanding of Sox9 expression at the 
pylorus. As with Nkx2-5, avian studies of Sox9 demonstrate that it is necessary for the proper 
formation of the pyloric epithelium. Mammalian studies have also shown that Sox9 expression is 
affected by loss of antral Six2. Our findings extend these observations by showing that pyloric 
Sox9 is expressed in a subset of Nkx2-5 and Gata3 double positive cells. In addition, loss of 
either Nkx2-5 or Gata3 abrogates Sox9 expression, suggesting that Sox9 expression depends on 
both of these genes. We also demonstrated that Nkx2-5, Gata3, and Sox9 are expressed within 
the newly characterized pyloric cords. Earlier studies had described these structures as gastric 
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ligaments, but their tissue composition and function was not examined [125].Our data 
demonstrate that these are in fact muscular structures whose formation depends on the 
expression of Nkx2-5 and Gata3. These findings present a series of new questions. What is the 
relationship (if any) between Nkx2-5 and IHPS? If Nkx2-5 and Gata3 are expressed 
independently of one another, what accounts for their similar expression domains and similar 
functions in pyloric muscular development? Does loss of pyloric Sox9 affect pyloric muscular 
development? What is the precise function of the pyloric cords, and how do they perform this 
function? In this chapter, I will address these questions and propose experiments that will allow 
us to answer them. Then I will discuss the implications of these answers and the eventual 
direction of pyloric developmental research.     
	
4.1 Investigating the relationship between Nkx2-5 and IHPS 
Among the many implications of the work presented here, the most clinically important is that 
Nkx2-5 is demonstrably involved in pyloric muscular development (see Chapter 2). Since Nkx2-5 
has been implicated in the pathogenesis of IHPS in recent GWAS studies [13], our findings 
provide a hypothesis for the mechanism by which Nkx2-5 gives rise to IHPS: specifically, that 
IHPS might result from overexpression of Nkx2-5 shortly after birth.  
 
The most direct assay for this hypothesis would be to generate a mouse model that overexpresses 
NKX2-5. I would utilize a previously described Nkx2-5 enhancer that has a pyloric-specific 
expression domain as a driver for Nkx2-5 cDNA expression [77].  Additionally, since wild-type 
NKX2-5 protein shows relatively low levels of transcriptional activity, due to the presence of a 
negative transactivating domain at the C-terminus of the protein [135], I will employ a highly 
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active version of NKX2-5 with residues 203-318 deleted (NKX2-5ΔC). This construct would 
then be used to create a transgenic mouse that would be assayed for morphological and signaling 
changes at the pylorus. Examining whole mount samples from such a mouse would presumably 
show ringed muscular expansion at the pylorus. In sections, we would expect this to be reflected 
by an expansion of the pyloric OLM, since loss of NKX2-5 appears to exclusively affect this 
tissue layer, though changes in the ICM might also be seen. These findings would demonstrate a 
direct link between NKX2-5 expression and pyloric OLM development. If such a muscular 
expansion were absent in the Nkx2-5 overexpression model, it would suggest that Nkx2-5 is 
necessary for the formation of the pyloric OLM, but it is not sufficient for its proliferation.  
 
Given the conflicting nature of the existing data on pyloric signaling [78, 80, 108, 109], and the 
lack of data demonstrating direct relationships between pyloric signaling molecules and 
transcription factors, it is difficult to speculate on how supraphysiologic NKX2-5 expression 
would affect the signaling environment at the pylorus. Since both our data and earlier reports 
have demonstrated that pyloric NKX2-5 and SOX9 are modulated in concert by different 
signaling and transcription factors, it may be that SOX9 expression would expand after NKX2-5 
overexpression. Also, since our data appear to suggest that Gata3 is expressed within the 
differentiated pyloric OLM it seems reasonable to hypothesize that Gata3 expression there 
would also increase. Presumably, however, this would be passive, due to expansion of the 
muscle rather than via direct regulation of Gata3 by Nkx2-5. 
 
Given the GWAS results, it would be of great interest to secure specimens from IHPS patients 
and to determine the expression levels of NKX2-5 (as well as GATA3 and SOX9) within those 
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samples relative to those seen in cadaverous controls. Since we see such large discrepancies 
between the avian and mammalian model, it would be reassuring to see our findings 
recapitulated in human tissue as it would suggest that the mouse pylorus is an appropriate model 
system in which to study IHPS. Finally, sequencing the Nkx2-5 locus in patients with the 
identified Nkx2-5 polymorphism could reveal the direct relationship between Nkx2-5 and IHPS. 
This, in combination with functional studies, would clarify whether the causative mutation 
within Nkx2-5 results in its overexpression, constitutive activation, or is completely unrelated to 
Nkx2-5 expression. This finding could then be used to generate more accurate IHPS mouse 
models. These in turn may allow us to better understand the relationship between Nkx2-5 and 
Gata3 and determine whether the latter gene also plays a role in IHPS. 
 
4.2  Regulation of Nkx2-5, Gata3 by known signaling molecules at the pylorus 
Interestingly, the region in which the pyloric musculature forms is marked earlier in development 
by the lack of lack of WNT signaling (Kiefer et al., 2012) as well as the lack of BMP signaling 
[79, 80].  However the regulatory relationship between Nkx2-5 and Gata3 and both of these 
signaling pathways is far from clear. Below, I will examine the rather confusing lines of 
evidence for the role of BMP and WNT signaling in pyloric development. 
 
WNT signaling and pyloric development 
Ectopic Wnt expression at the pylorus alters the expression of both NKX2-5 and GATA3 [109], 
but has opposite effects, expanding the NKX2-5 expression domain while reducing that of 
GATA3.  Confusing the issue, these data conflict with earlier data on effects of WNT signaling 
on Nkx2-5, as Barx1 and Bapx1 have both been shown to modulate gastric and pyloric WNT 
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expression but do not appear to affect the expression of Nkx2-5 [95, 108]. Interestingly, WNT 
expression is already absent at the pylorus by the time Gata3 expression is initiated at E11.5 [7, 
136] and could be absent even earlier. Indeed, WNT expression is necessary for the early pattern 
formation that results in the formation of the foregut-midgut junction, suggesting that it could be 
involved in demarcating the position of a pylorus-specific Nkx2-5 and Gata3 domain [136]. The 
simplest test of this is overexpression of Wnt or active β-catenin at the pylorus. This is exactly 
the approach taken by Kiefer et al. [109], but as mentioned, with opposite outcomes for Gata3 
and Nkx2-5. It is important to note, however, that these authors only studied Gata3 and Nkx2-5 
expression by whole mount in situ hybridization and it is altogether possible that in the critical 
cells of the OLM, the overexpression of WNT ligands might have suppressed both Nkx2-5 and 
Gata3. This needs to be carefully examined. Another caveat of the studies done by Kiefer et al. is 
the fact that a Six2-Cre driver was used to overexpress WNT9B. Six2 is expressed throughout the 
antrum, but whether Six2 is actually expressed in the cells of the OLM at the pylorus has not 
been established, and it is not clear whether Six2 and NKX2-5 and Gata3 are expressed in the 
same cells. Thus, while the phenotype of these mice was partial loss of pyloric stricture, their 
Figure 6 does seem to show that residual pyloric muscle is present [109]. It is not clear, 
therefore, whether Wnt overexpression is actually felt by the cells co-expressing GATA3 and 
NKX2-5 in this model. Indeed, WNT ligands are known to stick to extracellular matrix and do 
not diffuse very far from their source. To better test the function of WNT in regulating Nkx2-5 
and Gata3, it would be preferable to utilize a Cre construct that drives recombinase specifically 
in the cells that co-express these factors. Pyloric-specific enhancers from either Nkx2-5 or Gata3 
could be used for this purpose. Such tools are discussed below.   
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BMP signaling and pyloric development 
The effect of BMP signaling on pyloric development is equally puzzling. Early studies indicated 
that the pylorus is marked by a zone that is free of Bmp4 ligand expression [79, 80]. 
Additionally, expression of the Bmp antagonist, Grem1 was detected specifically at the pylorus 
[7]. Thus, it was speculated that the pylorus is a zone that lacks BMP signal reception. In support 
of this, Dr. Kate Walton in our laboratory has utilized a BMP signaling reporter mouse from 
Blank et al. [137, 138], that faithfully reports the reception of BMP signals and finds no evidence 
of BMP signal reception at the pylorus proper. Despite this, studies in the chick model indicate 
that both Nkx2-5 and Sox9 domains at the pylorus are induced by Bmp4. Bmp4 ligand is thought 
to be derived from surrounding stomach and intestinal mesenchyme and to diffuse into the 
pyloric region to regulate Nkx2-5 and Sox9. Indeed, overexpression of noggin affects pyloric 
development in the chick model [78]. A final piece of data confusing the picture is that after the 
loss of Six2, Bmp4 is enhanced at the pylorus and the pyloric constriction fails to form; this is 
accompanied by temporary loss of Nkx2-5 expression and loss of Sox9 expression, suggesting 
that Bmp4 suppresses rather than activates expression of these two genes [80]. 
 
To clarify these data, it will be necessary to first re-examine the BMP reporter mice to determine 
whether cells that express Nkx2-5 and Gata3 are positive or negative for BMP signaling. (It 
should be mentioned here that the use of the pSmad1/5/8 antibodies to stain for BMP signal 
transduction at the pylorus has not been successful in our hands). Second, a Bmp4 
overexpression experiment akin to the one performed above for Wnt, and using a pyloric-specific 
driver, would reveal whether restriction of Bmp from the pylorus is necessary for proper pyloric 
development and whether this affects Nkx2-5 and Gata3 expression. Interestingly, we have 
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examined the Grem1 knockout mice and find no phenotype at the pylorus, indicating that if a 
Bmp-free zone is required at the pylorus, such a zone is not established solely by the expression 
of Grem1 (Figure 4.1, 4.2). 
 
Clues from pyloric-specific enhancers 
Additional clues to factors that might be responsible for the regulation of Nkx2-5 and Gata3 
might be found in the enhancers that drive pyloric specific expression of both of these 
transcription factors, discussed below [77, 139](see Section 4.4, Figure 4.3). TRANSFAC 
analysis of both enhancers (which identifies putative transcription factor binding sites) identified 
possible sites for PAX4 and PAX6 in both enhancers. However, these are thought to be epithelial 
transcription factors, and it is not clear that either one of them is expressed at the pylorus. It is 
possible that these types of sites are occupied by other transcription factors. Nevertheless, this 
analysis provides little insight into common upstream regulatory mechanisms for Nkx2-5 and 
Gata3. It is possible that additional pyloric-specific enhancers exist for each gene and that these 
still unidentified regulatory regions will hold the clue to a common upstream regulatory pathway. 
Thus, while the data demonstrate that Barx1, Bapx1, Six2, Nkx2-5, and Gata3 all affect pyloric 
muscular development in a similar manner, there is no current data identifying a possible “master 
regulator” of pyloric smooth muscle among these genes.   
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Figure 4.1 Smooth muscle expression in the Grem1 knockout mouse 
E18.5 sections of wild-type (A-C) or Grem1 knockout (D-F) pylorus shows that smooth muscle 
expression is undisturbed in the absence of Grem1. Both the OLM and the ICM are of similar 
thickness in the knockout (E) and the wild-type (B) pylorus. 
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Figure 4.2 NKX2-5 and GATA3 expression in the Grem1 knockout pylorus 
E18.5 pyloric sections of wild-type (A-D) or Grem1 knockout (E-H) mice shows that the 
expression of both NKX2-5 and Gata3 are relatively undisturbed in the absence of Grem1. In 
both genotypes, NKX2-5 is expressed throughout the ICM and OLM, while Gata3 expression is 
largely limited to the OLM. 
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Figure 4.3 Binding sites in pyloric enhancers 
Sequences for the pylorus specific enhancers of NKX2-5 (A), Gata3 (B), and SOX9 (C) illustrate 
few common motifs. The enhancers for both NKX2-5 and SOX9 display binding sites for Gata3 
(yellow). The Gata3 and SOX9 enhancers both display binding sites for Nkx-25 (green), while 
only the Gata3 enhancer contains generic homeodomain binding sites. 
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4.3 Identification of pyloric targets of Nkx2-5 and Gata3 
 While Gata3 and Nkx2-5 may not regulate one another, co-expression of Gata3 or Nkx2-5 in the 
pyloric OLM, and the remarkably similar phenotypes seen in the loss of either gene, suggests 
that they likely interact in some way in pyloric signaling. This may be through the independent 
regulation of common targets, or through the participation of both proteins in a transcriptional 
complex that might function to drive muscle differentiation. Since both genes encode 
transcription factors, one approach to explore this further would be to determine the direct 
downstream targets of each protein.  
 
We could identify possible targets of these pyloric transcription factors using chromatin 
immunoprecipitation, followed by sequencing (ChIP-seq). This protocol allows us to uniquely 
identify occupied binding sites in potential pyloric target genes. Of particular interest would be 
finding targets that appear to have binding sites for both Nkx2-5 and Gata3, since their 
phenotypes suggest that they could regulate common genes (indeed, we already know that they 
are both required for Sox9 expression). To minimize noise within the assay, it would be ideal to 
assay only pyloric tissue. This could be accomplished through microdissection of the pylorus 
from the surrounding gastric and intestinal tissue. We could also use our existing Nkx2-5eGFP/+ or 
Gata3eGFP/+ reporter line and sort EGFP expressing cells for the ChIP analysis, limiting our 
analysis to only the Nkx2-5 or Gata3 positive cells at the pylorus. Narrowing the assay to this 
population would minimize noise, but will certainly limit the available tissue. These experiments 
are altogether feasible, since ChIP compatible antibodies for both genes have been previously 
tested [114, 139]. 
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The binding sequences for NKX2-5 and GATA3 are well-described [4, 5]. NKX2-5 shows 
heterogenous binding affinity to a number of similar DNA sequences [4]. Among these, the 
highest affinity sequence is 5’-TNNAGTG-3’. Since NKX2-5 is a homeodomain protein [4], it 
also has a moderate affinity for the generic homeodomain sequence, 5’-TAAT-3’. Due to the 
commonplace nature of that short sequence, binding to similar sequences may or may not 
indicate pylorus specific NKX2-5 activation. The Gata family of transcription factors is known 
to bind to the sequence 5’-A/TGATAA/G-3’, containing the central “GATA” motif for which the 
family is named. In silico analysis of the NKX2-5 and GATA3 targets implicated by this study 
will focus on these binding sites to determine potential gene targets for follow-up. To further 
narrow these potential targets, we will take advantage of microarray studies done earlier by our 
laboratory [7]. Those ChIP targets that are also clearly expressed at the pylorus will be 
prioritized. 
 
Nkx2-5, Gata3, and Srf 
The independent regulation of Gata3 and Nkx2-5 is surprising in light of their common 
phenotype with gene deletion: both result in lack of smooth muscle differentiation of the pyloric 
OLM fascicle. One attractive hypothesis to bring these elements together is to consider the idea 
that GATA3, NKX2-5 and SRF work together in a complex that regulates smooth muscle genes. 
In this case, the loss of any of the three factors could result in failure of smooth muscle 
formation/differentiation. SRF is a well described regulator of cardiac and smooth muscle 
differentiation [140-142], including the differentiated gastrointestinal smooth muscle marker 
αSMA [143]. Interestingly, a tri-molecular complex of NKX2-5, GATA4 and SRF is thought to 
regulate the expression of cardiac α-actin [141]. NKX2-5 and GATA4 appear to act 
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cooperatively and synergistically with SRF; interestingly, the DNA binding domain of NKX2-5 
was dispensable in this function [141]. To determine if such a complex forms in pyloric muscle, 
we would assay NKX2-5, GATA3, and SRF for possible protein-protein interactions using co-
immunoprecipitation assays (co-IP). Positive staining for GATA3 and NKX2-5 after the 
precipitation of SRF in pyloric tissue would strongly suggest that these genes cooperate in 
pyloric muscular regulation. Reporter assays for transcriptional activation in smooth muscle cells 
such as 10T1/2 cells could be used to further explore whether co-transfection of NKX2-5, 
GATA3 and/or SRF displays synergy in the regulation of smooth muscle genes such as αSMA 
and SM22α and to determine the domains of each factor that are required for these functions.  
 
4.4 Sox9 function at the pylorus 
At least one target of both NKX2-5 and GATA3 may be Sox9. In this regard, it is interesting that 
a 516 bp sequence about 28 kb upstream of the Sox9 locus appears to be responsible for SOX9 
expression in the node, notochord, gut, bronchial epithelium, and pancreas [144, 145]. No other 
Sox9 enhancer mapped to a gut region, suggesting that pyloric SOX9 expression is regulated by 
this region. Examination of this region appears to show a single binding site each for NKX2-5 
and GATA3 (Figure 4.4). This implicates Sox9 as an important convergence point for OLM 
development. Unfortunately, germline loss of SOX9 is incompatible with embryonic 
development [146]. Also, since SOX9 is expressed in both epithelium and mesenchyme at the 
pylorus, we cannot use a tool such as the CAGG-CreER mouse that we successfully employed 
for the conditional removal of Nkx2-5. Thus, investigating the role of  
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Figure 4.4 Expression of the NGRS-lacZ gene 
X-gal staining of the NGRS-lacZ reporter mouse shows strong staining at the pylorus and the 
spleen. (A) At E11.5, the spleen is beginning to develop and shows a lacZ positive cell 
population moving to the lateral stomach from the pylorus. (B) By E12.5 there is an obvious 
splenic shape on the lateral stomach. The pylorus also shows strong NGRS expression at this 
timepoint. (C) The spleen narrows and the stream of cells from the pylorus grows more limited. 
(D) By E14.5 there are few cells still traveling from the pylorus to the spleen. (E) By E16.5, the 
splenic expression is completely distinct from that at the pylorus. Pyloric expression is hidden by 
pancreatic tissue (Figure adapted from Fig 1. in Burn et al. 2008 and printed with permission 
from Elsevier) 
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Sox9 in pyloric function requires a mesenchyme-specific deletion of the gene. Since an Nkx2-5 
pylorus-specific enhancer has been defined [147](Figure 4.2), this region could be used to drive 
the expression of a pylorus-specific Cre. Using an existing Sox9f/f line, we could determine 
Sox9’s pyloric function.  
 
Analysis of such a pylorus-specific Sox9 knockout would proceed in a manner similar to that for 
the Nkx2-5 and Gata3 knockouts described in Chapter 2. It would be of interest to know whether 
there are changes in Nkx2-5 and Gata3 expression in the absence of Sox9. A microarray of the 
pylorus in the Sox9 conditional knockout mouse would allow us to determine how genes are 
altered in this knockout, and thus identify some of the Sox9 targets. We would expect this list to 
be a subset of the genes downstream of Nkx2-5 and Gata3 since pyloric Sox9 expression is 
dependent on both those genes. It is interesting to recall that Sox9 is expressed in a rather small 
subset of the cells that also express Gata3 and Nkx2-5. Because so few cells in the center of the 
OLM domain express Sox9, it is tempting to speculate that Sox9 could regulate a secreted 
signaling factor that could control the size of the OLM muscle. In this regard, it would be of 
interest to design a Sox9 overexpressing mouse model to see if this might have an overly 
developed pyloric muscle, another possible model for IHPS. 
 
   
4.5 Understanding the function of the pyloric cords 
Thus far, I have described experiments that could extend our understanding of pyloric signaling, 
especially as it relates to Nkx2-5, Gata3 and Sox9. However, the data in Chapter 3 present an 
interesting question which I have not yet addressed. Specifically, what is the function of the 
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pyloric ligaments? While earlier works have addressed the presence of the pyloric ligaments 
[125], they did not present experimental evidence to support a hypothesis as to their function. 
Our data suggest that the pyloric cords are smooth muscle structures continuous with the pyloric 
OLM and express several of the same genes that are expressed in the OLM. Thus, we 
hypothesize that the OLM and pyloric ligaments form one continuous structure that may function 
to control the flexure and/or position of the antrum relative to the duodenum.  
 
It would be of interest to determine whether in fetal or postnatal mice, disruption of these cords 
affects either the flexure of the stomach to the duodenum or the timing of the peristaltic 
contractions passing through this region. Thus, I would perform a series of experiments in E16.5 
and P2 mice in which one or both of the ligaments are surgically cut. Such a study could be done 
by partial dissection (without removing the entire stomach and duodenum from the mouse), or in 
culture.  We have previously described the successful culturing of short segments of intestine 
[148]. This protocol also works on early embryonic stomachs, allowing them to be cultured for a 
few days. Thus, we could culture E16.5 stomachs and observe the function of the ligaments. The 
ligaments could be induced to contract with the addition of neurotransmitters like acetylcholine, 
allowing the observation of the degree of flexure. Flux of a fluorescent dye injected into the 
stomach coud also be studied. A matched control mouse in which the abdominal cavity is opened 
but the cords are not severed would be used as a control to determine what normal flexure and 
flux should be in those situations. While such a culture system allows a greater deal of freedom 
in manipulation of the target organ, it is also a much more artificial system since there is no real 
food movement through the GI tract before birth. One additional caveat to these experiments is 
the substantial innervation of the pyloric region, most of which is inhibitory. Thus, dissection of 
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this region has the potential to alter peristalsis by itself, making these experiments somewhat 
technically challenging 
 
4.6 Conclusion 
The data presented in this thesis provide the first cellular and molecular characterization of the 
development of the pyloric OLM and the pyloric ligaments. These data also extend our current 
understanding of pyloric signaling by identifying the functions of Nkx2-5 and Gata3 at the 
mammalian pylorus. Since, at the pylorus, Nkx2-5 is expressed earlier and more widely than 
Gata3, we initially speculated that Nkx2-5 was an important regulator of Gata3. When we found 
that the two knockouts displayed highly similar phenotypes (see Chapter 2), we were even more 
ready to see that Nkx2-5 was upstream of Gata3. Yet, confounding expectations, the data 
indicated that Nkx2-5 does not regulate Gata3 expression at the pylorus. Indeed, our data suggest 
that the upstream regulation of these two genes during the course of pyloric development is 
independent. The idea that both genes could function in a similar pathway, perhaps in 
conjunction with SRF, could provide a unifying hypothesis to explain the similar phenotypes, 
linking the disparate muscular phenotypes into one coherent signaling tree. The expansion of this 
tree and the incorporation of previous data sets, like the Barx1, Bapx1, and Six2 studies, would 
greatly extend our current understanding of pyloric development and help to uncover the 
molecular defects responsible for idiopathic hypertrophic pyloric stenosis. 
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